Document:

Registration Rights Agreement

 Exhibit 4.6 
 REGISTRATION RIGHTS AGREEMENT 
 THIS REGISTRATION RIGHTS AGREEMENT (this
“Agreement”) is entered into as of March 31, 2008, by and between BISON CAPITAL EQUITY PARTNERS II-A, L.P., a Delaware limited liability partnership, and BISON CAPITAL EQUITY PARTNERS II-B, L.P., a Delaware limited
liability partnership (collectively, “Purchaser”), on the one hand, and CENTER FOR WOUND HEALING, INC., a Nevada corporation (the “Company”), on the other hand. 
 RECITALS 
 A. The Company and
Purchaser are parties to that certain Securities Purchase Agreement dated as of even date herewith (the “Purchase Agreement”) pursuant to which, among other things, on the date hereof, (i) the Company is issuing and selling to
Purchaser, and Purchaser is purchasing from the Company, a Senior Secured Subordinated Promissory Note, due March 31, 2013, in the initial principal amount of Twenty Million Dollars ($20,000,000) and (ii) the Company is issuing and selling
to Purchaser, and Purchaser is purchasing from the Company warrants to purchase shares of Common Stock of the Company. 
 B. The execution
and delivery of this Agreement is a condition precedent to the consummation of the transactions contemplated by the Purchase Agreement. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 
 1. DEFINITIONS. Unless
otherwise defined herein, all capitalized terms used herein shall have the meanings set forth in the Purchase Agreement. In addition to the capitalized terms defined elsewhere in this Agreement, the following terms shall have the meanings specified
below: 
 “Agreement” shall have the meaning specified in the preamble to this Agreement. 
 “Purchaser Indemnified Party” shall have the meaning specified in Section 4.1. 
 “Capital Stock” shall mean any and all shares, interests, participations or other equivalents (however designated) of capital
stock of a corporation, any and all equivalent ownership interests in a Person (other than a corporation) and any and all warrants or options to purchase any of the foregoing. 
 “Common Stock” shall mean the Company’s common stock, par value $0.001 per share (including, without limitation, the Warrant
Securities), or any other Capital Stock of the Company (including, without limitation, any preferred stock) into which such stock is reclassified or reconstituted. 
 “Company” shall have the meaning specified in the preamble to this Agreement. 
  

 -1- 

 “Demanding Holders” shall mean Purchaser or, if Purchaser does not hold a
majority of the Registrable Securities at any time, the holders of a majority of Registrable Securities then outstanding. 
 “Demand Registration” shall have the meaning specified in Section 2.1(a). 
 “Effective Date” shall mean the date that the Registration Statement has been declared effective by the SEC. 
 “Effectiveness Deadline” shall mean the date which is 180 days after the Company’s receipt of a request for a Demand Registration. 
 “Filing Deadline” shall have the meaning specified in Section 3.1(a). 
 “Indemnified Party” shall have the meaning specified in Section 4.3. 
 “Indemnifying
Party” shall have the meaning specified in Section 4.3. 
 “Liability” shall mean any loss,
damage, claim, proceeding or other liability. 
 “Maximum Number of Shares” shall have the meaning specified in
Section 2.1(d) 
 “Piggy-Back Registration” shall have the meaning specified in
Section 2.2(a). 
 “Purchase Agreement” shall have the meaning set forth in the recitals to this
Agreement. 
 “Purchaser” shall have the meaning specified in the preamble to this Agreement. 
 “Register”, “registered” and “registration” shall mean a registration effected by
preparing and filing a Registration Statement or similar document in compliance with the Securities Act, and the applicable rules and regulations thereunder, and such Registration Statement becoming effective. 
 “Registrable Securities” shall mean, collectively, (a) any and all Warrant Securities and any other shares of Capital Stock
or other securities issued or issuable upon any stock dividend, stock split, recapitalization, merger, consolidation or similar event with respect to the Warrant Securities and (b) any shares of Common Stock owned as of the date hereof or
hereafter acquired, directly or indirectly and jointly or separately, by Bison Capital Equity Partners II-A, L.P. or Bison Capital Equity Partners II-B, L.P. As to any particular Registrable Securities, such securities shall cease to be Registrable
Securities when (i) a Registration Statement covering such securities has been declared effective under the Securities Act and such securities have been sold pursuant to such Registration Statement, (ii) such securities have been
distributed to the public pursuant to Rule 144 or Rule 144A (or any successor provisions) under the Securities Act, (iii) such securities may be sold pursuant to Rule 144(k) (or any successor provision) without limitation as to volume, as
determined by counsel to the Company pursuant to a written opinion to that effect; or (iv) such securities have ceased to be outstanding. 
 “Registration Delay Payments” shall have the meaning specified in Section 3.5. 
  

 -2- 

 “Registration Failure” shall have the meaning specified in
Section 3.5. 
 “Registration Statement” shall mean a registration statement on any form for which the
Company then qualifies or which counsel for the Company deems appropriate and which form is available for the sale of the Registrable Securities to be registered thereunder in accordance with the intended method of distribution thereof. 

“Underwriter” shall mean a securities dealer who purchases any Registrable Securities as principal in an underwritten offering
and not as part of such dealer’s market-making activities. 
 “Warrant” or “Warrants”
shall mean the “Warrant” as such term is defined in the Purchase Agreement and any other warrant issued to Purchaser by the Company (if any). 
 “Warrant Securities” shall mean any and all shares of Capital Stock or other securities of the Company issued or issuable upon exercise of, or otherwise under, any Warrant, including without
limitation any other securities issued on account of any such securities as the result of any dividend, stock split or other distribution (including, without limitation, in connection with a merger, consolidation, recapitalization or other
reorganization), in exchange for or in replacement of, such securities. For the purposes of this Agreement, the holder of any Warrant or any portion thereof shall be deemed to be the holder of the shares of Capital Stock issuable upon exercise of
such Warrant or such portion thereof, and, to the extent such shares of Capital Stock constitute Registrable Securities, such holder shall be deemed to be the holder of such Registrable Securities. 
 2. REGISTRATION RIGHTS. 
 2.1 Demand Registration.

 (a) Request for Registration. From time to time after the Company is able to file a Registration Statement (and the Company shall
in any event be able to do so by October 15, 2008), the Demanding Holders may make a written request for registration under the Securities Act of all or part (but in no event less than twenty five percent (25%)) of their Registrable
Securities (a “Demand Registration”). Such request for a Demand Registration must specify the number of shares of Registrable Securities proposed to be sold and must also specify the intended method of disposition thereof.
Upon any such request, the Demanding Holders shall be entitled to have their Registrable Securities included in the Demand Registration, subject to Section 2.1(d) and the proviso set forth in Section 3.1(a). The Company shall
not be obligated to effect more than two (2) Demand Registrations under this Section 2.1(a). 
 (b) Effective
Registration. Except in the case of a withdrawal governed by the last sentence of Section 2.1(e), a registration will not count as a Demand Registration until the Registration Statement covering the Registrable Securities that are the
subject of such Demand Registration has become effective and the Company has complied with all of its obligations under this Agreement with respect thereto; provided, however, that, after such Registration Statement has been declared
effective, if the offering of Registrable Securities pursuant to such Demand Registration is interfered with by any stop order, injunction or other order or requirement of the SEC or any other governmental agency or court, such Demand Registration
will be deemed not to have become effective during the period of such interference. 
  

 -3- 

 (c) Underwritten Offering. If the Demanding Holders so elect, the offering of such Registrable
Securities pursuant to such Demand Registration shall be in the form of an underwritten offering. The Demanding Holders shall select one or more firms of investment bankers to act as the managing Underwriter or Underwriters in connection with such
offering and shall select any additional managers to be used in connection with the offering. 
 (d) Reduction of Offering. If the
managing Underwriter or Underwriters for a Demand Registration that is to be an underwritten offering advises the Company and the Demanding Holders, in writing, that the dollar amount or number of shares of Registrable Securities which the Demanding
Holders desire to sell, taken together with all other shares of Common Stock or other securities which the Company desires to sell and the shares of Common Stock or other securities, if any, as to which registration has been requested pursuant to
any outstanding piggy-back registration rights or which other stockholders of the Company desire to sell, exceeds the maximum dollar amount or number that can be sold in such offering without adversely affecting the proposed offering price, the
timing, the distribution method or the probability of success of such offering (the “Maximum Number of Shares”), then the Company shall include in such registration: 
 (i) first, the shares of Common Stock that the Company desires to sell that can be sold without exceeding the Maximum Number of Shares; 
 (ii) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing clause (i), the Registrable Securities as to which
Demand Registration has been requested by the Demanding Holders (pro rata in accordance with the number of shares of Registrable Securities held by each Demanding Holder, regardless of the number of shares of Registrable Securities which such
Demanding Holder has requested be included in such registration) that can be sold without exceeding the Maximum Number of Shares; 
 (iii)
third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (i) and (ii), the shares of Common Stock for the account of other persons that the Company is obligated to register pursuant to any other
registration rights agreement (to be allocated among the persons requesting inclusion in such registration pursuant to such agreements pro rata in accordance with the number of shares of Common Stock with respect to which such person has the right
to request such inclusion under such agreements, regardless of the number of shares which such person has actually requested be included in such registration) that can be sold without exceeding the Maximum Number of Shares; and 
 (iv) fourth, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (i), (ii) and (iii), the shares of
Common Stock that other stockholders desire to sell that can be sold without exceeding the Maximum Number of Shares. 
 (e)
Withdrawal. If the Demanding Holders or any of them disapprove of the terms of any underwriting or are not entitled to include all of their Registrable Securities in any offering, such Demanding Holders may elect to withdraw from such
offering by giving written notice to the Company and the Underwriter of their request to withdraw prior to the effectiveness 

  

 -4- 

 
of the Registration Statement. If the Demanding Holders or any of them withdraw from a proposed offering relating to a Demand Registration and, solely as a
result of such withdrawal the Registration Statement is withdrawn prior to being declared effective, such registration shall count as a Demand Registration provided for in Section 2.1(a) unless the withdrawing Demanding Holders pay their
pro rata share (based upon the number of shares to be included in such Registration Statement) of the expenses incurred in connection with such Registration Statement. 
 2.2 Piggy-Back Registration. 
 (a) Piggy-Back Rights. If at any time the Company proposes to
file a registration statement under the Securities Act with respect to an offering of Capital Stock by the Company for its own account or by stockholders of the Company for their account (or by the Company and by stockholders of the Company) other
than a registration statement (i) on Form S-4 or S-B (or any substitute or successor form that may be adopted by the SEC), (ii) filed in connection with any employee stock option or other benefit plan, (iii) for an exchange offer or
offering of securities solely to the Company’s existing stockholders, or (iv) for a dividend reinvestment plan, then the Company shall (x) give written notice of such proposed filing to the holders of Registrable Securities as soon as
practicable but in no event less than thirty (30) days before the anticipated filing date, which notice shall describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, the jurisdictions
in which the Company will attempt to qualify such securities under the applicable blue sky or other state securities laws and the name of the proposed managing underwriter or underwriters, if any, of the offering; and (y) offer to the holders
of Registrable Securities in such notice the opportunity to register any number of shares of Registrable Securities as such holders may request in writing within 30 days following receipt of such notice (a “Piggy-Back
Registration”). The Company shall cause such Registrable Securities to be included in such registration and shall use its best efforts to cause the managing underwriter or underwriters of a proposed underwritten offering to permit the
Registrable Securities requested to be included in a Piggy-Back Registration to be included on the same terms and conditions as any similar securities of the Company and to permit the sale or other disposition of such Registrable Securities in
accordance with the intended method of distribution thereof. 
 (b) Reduction of Offering – Company-Initiated Registrations. If
the managing underwriter or underwriters for a Piggy-Back Registration that is to be an underwritten offering of shares for the Company’s account advises the Company and the holders of Registrable Securities in writing that the dollar amount or
number of the shares of securities which the Company desires to sell, taken together with the Registrable Securities as to which registration has been requested under Section 2.2(a) and such Common Stock or other securities, if any, as
to which registration has been requested pursuant to any outstanding piggy-back registration rights or which other stockholders of the Company desire to sell, exceeds the Maximum Number of Shares, then the Company shall include in such registration:

 (i) first, the shares of Common Stock or other securities that the Company desires to sell that can be sold without exceeding the Maximum
Number of Shares; 
  

 -5- 

 (ii) second, to the extent that the Maximum Number of Shares has not been reached under the foregoing
clause (A) of this clause (i), the Registrable Securities as to which registration has been requested Section 2.2(a) and the shares of Common Stock or other securities, if any, as to which registration has been requested pursuant to
other outstanding piggy-back registration rights (to be allocated among the persons requesting inclusion in such registration pro rata in accordance with the number of shares of Common Stock with respect to which such person has the right to request
such inclusion under its respective piggy-back registration agreement(s), regardless of the number of shares which such person has actually requested be included in such registration) that can be sold without exceeding the Maximum Number of Shares;
and 
 (iii) third, to the extent that the Maximum Number of Shares has not been reached under the foregoing clauses (A) and
(B) of this clause (i), the securities that other stockholders desire to sell that can be sold without exceeding the Maximum Number of Shares. 
 (c) Reduction of Offering — Stockholder-Initiated Registrations. If the managing underwriter or underwriters for a Piggy-Back Registration initiated by stockholders of the Company pursuant to demand registration rights
(“Initiating Holders”) that is to be an underwritten offering advises the Company and the holders of Registrable Securities in writing that the dollar amount or number of shares of Common Stock or other securities which the
Company desires to sell, taken together with the Registrable Securities as to which registration has been requested under Section 2.2(a) and the shares of Common Stock or other securities, if any, as to which registration has been
requested pursuant to any outstanding piggy-back registration rights or which other stockholders of the Company desire to sell, exceeds the Maximum Number of Shares, then the Company shall include in such registration: 
 (i) first, the shares of Common Stock or other securities as to which demand registration has been requested by the Initiating Holders; 
 (ii) second, to the extent the Maximum Number of Shares has not been reached under the foregoing clause (A) of this clause (i), and subject to any
priority rights of any other stockholders of the Company, the shares of Common Stock or other securities that the Company desires to sell that can be sold without exceeding the Maximum Number of Shares; 
 (iii) third, to the extent the Maximum Number of Shares has not been reached under the foregoing clauses (A) and (B) of this clause (i), the
Registrable Securities as to which registration has been requested pursuant to Section 2.2(a) and the shares of securities, if any, as to which registration has been requested pursuant to other outstanding piggy-back registration rights
(to be allocated among the persons requesting inclusion in such registration pro rata in accordance with the number of shares of securities with respect to which such person has the right to request such inclusion under its respective piggy-back
registration agreement(s), regardless of the number of shares which such Person has actually requested be included in such registration) that can be sold without exceeding the Maximum Number of Shares; and 
 (iv) fourth, to the extent the Maximum Number of Shares has not been reached under the foregoing clauses (A), (B) and (C) of this clause (i),
the securities that other stockholders desire to sell that can be sold without exceeding the Maximum Number of Shares. 
  

 -6- 

 (d) Withdrawal. Any holder of Registrable Securities may elect to withdraw such holder’s
request for inclusion of Registrable Securities in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness of the registration statement giving rise to such Piggy-Back Registration
Rights. The Company may also elect to withdraw such registration statement at any time prior to the effectiveness of such registration statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the holders of
Registrable Securities in connection with such Piggy-Back Registration as provided in Section 3.3. 
 2.3 Registrations on
Form S-3. The holders of Registrable Securities may at any time request in writing that the Company register the resale of any or all of such Registrable Securities on Form S-3 (or any similar short-form registration which may be available at
such time). Upon receipt of such written request, the Company will promptly give written notice of the proposed registration to all other holders of Registrable Securities, and, as soon as practicable thereafter, effect the registration of all or
such portion of such holder’s or holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other holder or holders joining in such request as are specified in a
written request given within 15 days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration pursuant to this Section 2.3 if
(a) the Company is not eligible to use a Form S-3 (or any successor form) to register such Registrable Securities, (b) the holders propose to effect an underwritten offering, or (c) the Company furnishes to the holders a certificate
signed by the Chief Executive Officer or President of the Company stating that, in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental to the Company and its stockholders for such Form S-3
registration to be effected at such time, in which event the Company shall have the right to defer the filing of the Form S-3 Registration Statement for only that period of time as the Board of Directors in good faith reasonably deems necessary to
avoid such material detriment to the Company, but, in any case, not more than ninety (90) days after receipt of the request of the holder or holders under this Section 2.3, and the deferral shall not be for more than that number of
shares of Registrable Securities that are required to be deferred to avoid such material detriment to the Company; provided, however, that (i) the Company shall in no event be entitled to defer registration if the deferral is
caused by, will cause or arises out of a Default or Event of Default under the Purchase Agreement, or if the facts or circumstances for such deferral existed at the time that a registration right held by another holder of Capital Stock was exercised
and no deferral was requested, and (ii) the Company shall not be allowed to exercise this deferral right more than once in any three hundred sixty-five (365)-day period. The Company shall use its best efforts to maintain each Registration
Statement under this Section 2.3 until (i) the Registrable Securities covered thereby have been sold or (ii) all Registrable Securities may be sold pursuant to Rule 144(k) (or any successor provision) without limitation as to
volume, as determined by counsel to the Company pursuant to a written opinion to that effect. Registrations effected pursuant to this Section 2.3 shall not be counted as Demand Registrations effected pursuant to Section 2.1.

 2.4 Purchase (and Exercise) of Warrant by the Underwriters. Notwithstanding any other provision of this Agreement to the contrary
but subject to compliance with the Securities Act and applicable blue sky laws, in connection with any Demand Registration or Piggy-Back Registration which is to be an underwritten offering, to the extent all or any portion of the 

  

 -7- 

 
Registrable Securities to be included in such registration consist of shares of Common Stock issuable upon exercise of any Warrant or any portion thereof,
the holders of such Registrable Securities may request that the Underwriter or Underwriters purchase (and exercise) such Warrant or any portion thereof rather than require the holders of the Registrable Securities to exercise such Warrant or portion
thereof in connection with such registration unless the Underwriters inform such holders that such a purchase and exercise of such Warrant will materially and adversely affect the proposed offering. The Company shall take all such action and provide
all such assistance as may be reasonably requested by the holders of Registrable Securities to facilitate any such purchase (and exercise) of any Warrant agreed to by the Underwriter or Underwriters, including, without limitation, issuing the Common
Stock issuable upon the exercise of such Warrant or any portion thereof to be issued within such time period as will permit the Underwriters to make and complete the distribution contemplated by the underwriting. 
 2.5 Time of Exercise. Holders of the Registrable Securities may exercise registration rights pursuant to this Agreement at any time or from time
to time, so long as such holders continued continue to hold Registrable Securities. 
 3. REGISTRATION PROCEDURES. 
 3.1 Filings; Information. If and whenever the Company is required to effect the registration of any Registrable Securities under the Securities Act
pursuant to Section 2, the Company shall use its best efforts to effect the registration and the sale of such Registrable Securities in accordance with the intended method of disposition thereof as expeditiously as practicable, and in
connection with any such request: 
 (a) Filing Registration Statement. 
 (i) Subject to clause (ii) directly below, the Company shall, as expeditiously as possible, prepare and file, within sixty (60) days after
receipt of a request for a Demand Registration pursuant to Section 2.1 (the “Filing Deadline”), with the SEC a Registration Statement, and shall use its best efforts to cause such Registration Statement to become
and remain effective for the period required by Section 3.1(c). 
 (ii) If reasonably requested by the managing Underwriter or
Underwriters or a holder of Registrable Securities included in a Registration Statement, the Company shall immediately incorporation in a prospectus supplement or post-effective amendment such necessary information as the managing Underwriters or
holders of a majority in number of the Registrable Securities included in such Registration Statement reasonably request to have included therein relating to the plan of distribution with respect to such Registrable Securities, including, without
limitation, information with respect to the amount of Registrable Securities being sold to such Underwriters, the purchase price being paid therefor by such Underwriters and with respect to any other terms of the underwritten offering of the
Registrable Securities to be sold in such offering. The Company shall also make all required filings of such prospectus supplement or such post-effective amendment as soon as notified of the matters to be incorporated in such prospectus supplement
or post-effective amendment. 
  

 -8- 

 (b) Copies. 
 (i) The Company shall, prior to filing a Registration Statement or prospectus or any amendment or supplement thereto, furnish, without charge, to the holders of Registrable Securities included in such registration,
such holders’ legal counsel, and the managing Underwriter or Underwriters for such registration, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case,
including all exhibits thereto and documents incorporated by reference therein), the prospectus included in such Registration Statement (including each preliminary prospectus), and such other documents as the holders of Registrable Securities
included in such registration or such other documents as legal counsel for any such holder may request in order to facilitate the disposition of the Registrable Securities owned by such holders. Promptly prior to the filing of any of the documents
described in the preceding sentence, the Company shall make such changes in any such document prior to filing thereof as such holders’ legal counsel or such managing Underwriter or Underwriters may reasonably request. 
 (ii) At the request of a holder of Registrable Securities included in a Registration Statement, the Company shall furnish to such holder and to each
managing Underwriter or Underwriters for such registration, without charge, at least one manually signed copy of the Registration Statement and any post-effective amendment thereto, including financial statements and schedules, all exhibits and all
other documents incorporated therein by reference. 
 (iii) Upon request of a holder of Registrable Securities included in a Registration
Statement or a managing Underwriter for such registration, the Company shall furnish as many copies of the prospectus included in such Registration Statement (including each preliminary prospectus) and any amendment or supplement thereto as such
holder or Underwriter may reasonably request. The Company hereby consents to the use of such prospectus or any amendment or supplement thereto by each of such holders and such Underwriters, if any, in connection with the offering and sale of the
Registrable Securities covered by such prospectus and any amendment or supplement thereto. 
 (c) Amendments and Supplements. The
Company shall prepare and file with the SEC such amendments, including post-effective amendments, and supplements to such Registration Statement and the prospectus used in connection therewith as may be necessary to keep such Registration Statement
effective and in compliance with the provisions of the Securities Act until (i) all Registrable Securities and other securities covered by such Registration Statement have been disposed of in accordance with the intended methods of disposition
set forth in such Registration Statement (which period shall not exceed the sum of 180 days plus any period during which any such disposition is interfered with by any stop order, injunction or other order or requirement of the SEC or any
governmental agency or court), (ii) such securities have been withdrawn or (iii) all Registrable Securities may be sold pursuant to Rule 144(k) (or any successor provision) without limitation as to volume, as determined by counsel to the
Company pursuant to a written opinion to that effect;. 
 (d) Notification. After the filing of the Registration Statement, the
Company shall promptly, and in no event more than two Business Days after such filing, provide written notice to the holders of Registrable Securities included in such Registration Statement of: 

  

 -9- 

 
(i) when such Registration Statement or prospectus relating thereto is filed (ii) when such Registration Statement becomes effective, (iii) when
any post-effective amendment to such Registration Statement becomes effective, (iv) any stop order issued or threatened by the SEC, (v) the receipt by the Company of any notification with respect to the suspension of the qualification of
the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, (vi) of any request by the SEC for any amendment or supplement to such Registration Statement or any prospectus
relating thereto or for additional information or (vii) of the occurrence of an event requiring the preparation of a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of the securities covered by such
Registration Statement, such prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading. In connection with the
events described in the immediately preceding clause (iv), the Company shall take all actions required to prevent the entry of such stop order or to remove it if entered. In connection with the events described in clauses (vi) and (vii), the
Company shall promptly make available to the holders of Registrable Securities included in such a Registration Statement any such supplement or amendment; except that before filing with the SEC a Registration Statement or prospectus or any amendment
or supplement thereto, including documents incorporated by reference, the Company shall furnish to the holders of Registrable Securities included in such Registration Statement and to the legal counsel for any such holders, copies of all such
documents proposed to be filed sufficiently in advance of filing to provide such holders and legal counsel with a reasonable opportunity to review such documents and comment thereon, and the Company shall not file any Registration Statement or
prospectus or amendment or supplement thereto, including documents incorporated by reference, to which such holders or legal counsel object on a timely basis in light of the requirements of the Securities Act or any other applicable laws and
regulations. 
 (e) State Securities Laws Compliance. The Company shall (i) register or qualify the Registrable Securities
covered by the Registration Statement under such securities or blue sky laws of such jurisdictions in the United States as the holders of Registrable Securities included in such Registration Statement (in light of their intended plan of
distribution) may request and (ii) cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental agencies or authorities in the United States as may be necessary and do any
and all other acts and things that may be necessary or advisable to enable the holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions;
provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this clause (e), or subject itself to taxation in any such
jurisdiction. 
 (f) Agreements for Disposition. The Company shall enter into customary agreements (including, if applicable, an
underwriting agreement in customary form) and take such other actions as are reasonably required in order to expedite or facilitate the disposition of such Registrable Securities. The representations, warranties and covenants of the Company in any
underwriting agreement which are made to or for the benefit of any Underwriters shall also be made to and for the benefit of the holders of Registrable Securities included in the applicable Registration Statement. No holder of Registrable Securities
included in such Registration Statement shall be required to make any representations or warranties in the underwriting 

  

 -10- 

 
agreement except, if applicable, with respect to such holder’s organization, good standing, authority, title to Registrable Securities, lack of conflict
of such sale with such holder’s material agreements and organizational documents, and with respect to written information relating to such holder that such holder has furnished in writing expressly for inclusion in such Registration Statement.

 (g) Cooperation. The Company’s Chief Executive Officer, President, Chief Financial Officer, Senior Vice Presidents and any
other members of management shall provide reasonable cooperation (which shall not materially interfere with the business of the Company) in any offering of Registrable Securities hereunder, which cooperation shall include, without limitation, the
preparation of the Registration Statement with respect to such offering and all other offering materials and related documents, and participation in meetings with Underwriters, attorneys, accountants and potential investors. 
 (h) Records. The Company shall make available for inspection by the holders of Registrable Securities included in such Registration Statement, any
underwriter participating in any disposition pursuant to such Registration Statement and any attorney, accountant or other professional retained by any holder of Registrable Securities included in such Registration Statement or any Underwriter, all
financial and other records, pertinent corporate documents and properties of the Company, as may be necessary to enable them to exercise their due diligence responsibility, and cause the Company’s officers, directors and employees to supply all
information requested by any of them in connection with such Registration Statement. 
 (i) Opinions and Comfort Letters. The Company
shall furnish to each holder of Registrable Securities included in any Registration Statement a signed counterpart, addressed to such holder, of (i) any opinion of counsel to the Company delivered to any Underwriter and (ii) any comfort
letter from the Company’s independent public accountants delivered to any Underwriter. In the event no legal opinion is delivered to any Underwriter, the Company shall furnish to each holder of Registrable Securities included in such
Registration Statement, at any time that such holder elects to use a prospectus, an opinion of counsel to the Company to the effect that the Registration Statement containing such prospectus has been declared effective and that no stop order is in
effect. 
 (j) Earnings Statement. The Company shall comply with all applicable rules and regulations of the SEC and the Securities
Act, and make available to its stockholders, as soon as practicable, an earnings statement covering a period of twelve (12) months, (1) commencing at the end of any month in which Registrable Securities are sold to underwriters in an
underwritten offering, or (2) if not sold to underwriters in such an offering, beginning with the first month commencing after the effective date of the Registration Statement, which statements shall cover said 12-month period. Such earnings
statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder. 
 (k) Listing. The
Company shall use its best efforts to cause all Registrable Securities included in any registration to be listed on such exchanges or otherwise designated for trading in the same manner as similar securities issued by the Company are then listed or
designated or, if no such similar securities are then listed or designated, in a manner satisfactory to the holders of a majority of the Registrable Securities included in such registration. 
  

 -11- 

 (1) Certificates. The Company shall reasonably cooperate with the holders of Registrable
Securities included in a Registration Statement and the managing Underwriters, if any, to facilitate the timely preparation and delivery of certificates or book entry securities representing Registrable Securities to be sold and not bearing any
restrictive legends and enable such Registrable Securities to be in such denominations and registered in such names as the managing Underwriters may request at least two (2) Business Days prior to any sale of Registrable Securities to the
Underwriters. 
 3.2 Obligation to Suspend Distribution. Upon receipt of any notice from the Company of the happening of any event of
the kind described in Section 3.1(d)(vi) or Section 3.1(d)(vii), each holder of Registrable Securities included in any registration shall immediately discontinue disposition of such Registrable Securities pursuant to the
Registration Statement covering such Registrable Securities until such holder receives the supplemented or amended prospectus contemplated by Section 3.1(d)(vi) or Section 3.1(d)(vii), and, if so directed by the Company, each
such holder will deliver to the Company all copies, other than permanent file copies then in such holder’s possession, of the most recent prospectus covering such Registrable Securities at the time of receipt of such notice. 
 3.3 Registration Expenses. The Company shall pay all expenses incurred in connection with any Demand Registration pursuant to
Section 2.1 and any Piggy-Back Registration pursuant to Section 2.2, and all expenses incurred in performing or complying with the Company’s obligations under this Section 3, whether or not the Registration
Statement becomes effective, in each case including, but not limited to: (a) all registration and filing fees; (b) fees and expenses of compliance with securities or blue sky laws (including fees and disbursements of counsel in connection
with blue sky qualifications of the Registrable Securities); (c) printing expenses; (d) the Company’s internal expenses (including, without limitation, all salaries and expenses of its officers and employees); (e) the fees and
expenses incurred in connection with the listing of the Registrable Securities as required by Section 3.1(k); (f) fees and disbursements of counsel for the Company and fees and expenses of independent certified public accountants
retained by the Company (including the expenses or costs associated with the delivery of any opinions or comfort letters requested pursuant to Section 3.1(i)); (g) the fees and expenses of any special experts retained by the Company
in connection with such registration; (h) securities act liability insurance if the Company so desires or if the underwriters so require; (i) all fees and expenses of not more than one counsel for all holders of Registrable Securities
included in such Registration Statement; (j) all other fees and expenses incurred by the holders of Registrable Securities included in such Registration Statement in connection with their participation in such registration, including, without
limitation, the fees and expenses of such holders’ accountants and other experts; and (k) fees and disbursements of underwriters (excluding discounts, commissions or fees of underwriters, selling brokers, dealer managers or similar
securities industry professionals relating to the distribution of the Registrable Securities or legal expenses of any person other than the Company, the underwriters and the holders of the Registrable Securities). 
 3.4 Information. The holders of Registrable Securities shall provide such information as reasonably requested by the Company in connection with
the preparation of any Registration Statement, including amendments and supplements thereto, in order to effect the registration of any Registrable Securities under the Securities Act pursuant to Section 2. 
  

 -12- 

 3.5 Effect of Failure to File and Obtain and Maintain Effectiveness of Registration Statement. If
(a) a Registration Statement covering all of the Registrable Securities required to be covered thereby and required to be filed by the Company pursuant to this Agreement is (i) not filed with the SEC on or before the respective Filing
Deadline or (ii) not declared effective by the SEC on or before the respective Effectiveness Deadline or (b) on any day after the Effective Date sales of all of the Registrable Securities required to be included on such Registration
Statement cannot be made (each of clauses (a) and (b), a “Registration Failure”) then, as partial relief for the damages to any holder by reason of any such delay in or reduction of its ability to sell the underlying
shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity), the Company shall pay to each holder of Registrable Securities relating to such Registration Statement an amount in cash per month
equal to (A) two percent (2%) of the face amount of the securities being requested to be registered multiplied by (B) the number of Registrable Securities being requested to be registered or, if registered, remaining to be sold;
provided, that after the first ninety (90) days of a Registration Failure, the amount of such damages shall increase by an additional amount per month (and compound monthly) equal to (A) two percent (2%) of the face amount of
the securities being requested to be registered multiplied by (B) the number of Registrable Securities being requested to be registered or, if registered, remaining to be sold. The payments to which a holder shall be entitled pursuant to this
Section 3.5 are referred to herein as “Registration Delay Payments”. In the event that the Registration Failure is due solely to the SEC applying Rule 415 under the Securities Act (or any successor rule) to
prevent any part of the Registrable Securities from being included in a Registration Statement, the Registration Delay Payments shall be waived solely as to the portion of such Registrable Securities that are not permitted to be registered by the
SEC pursuant to Rule 415, and such waiver shall last only for the period during which the SEC prevents registration solely pursuant to Rule 415. Registration Delay Payments shall be paid on the earlier of (i) the last day of the calendar month
during which such Registration Delay Payments are incurred or (ii) the third Business Day after the event or failure giving rise to the Registration Delay Payments is cured. In the event the Company fails to make Registration Delay Payments in
a timely manner, such Registration Delay Payments shall bear interest at the rate of one percent (1.0%) per month (prorated for partial months) until paid in full. The Registration Delay Payments with respect to any one Registration Failure
shall in no event exceed an amount equal twenty percent (20%) of the face amount of the securities being requested to be registered multiplied by the number of Registrable Securities being requested to be registered or, if registered, remaining
to be sold. 
 4. INDEMNIFICATION AND CONTRIBUTION. 
 4.1 Indemnification by the Company. The Company agrees to indemnify and hold harmless (a) Purchaser (including its general and limited partners) and each holder of Registrable Securities, and (b) the
respective officers, employees, affiliates, directors, partners, managers, members and agents, and each person, if any, who controls Purchaser or any holder of Registrable Securities within the meaning of Section 15 of the Securities Act or
Section 20 of the Exchange Act (each, a “Purchaser Indemnified Party”), from and against any Liability to which any Purchaser Indemnified Party may become subject under the Securities Act or the Exchange Act or any other
statute or common law, insofar as such Liability arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact made in connection with the sale of Registrable Securities or shares of Common Stock,
whether or not such statement is 

  

 -13- 

 
contained or incorporated by reference in any Registration Statement or prospectus relating to the Registrable Securities (as amended or supplemented if the
Company shall have furnished any amendments or supplements thereto) or any preliminary prospectus, (ii) any omission or alleged omission to state a material fact required to be stated in any Registration Statement or prospectus or necessary to
make the statements therein not misleading, or (iii) any violation by the Company of any Federal, state or common law, rule or regulation applicable to the Company and relating to action required of or inaction by the Company in connection with
such registration. The Company also shall promptly, but in no event more than ten (10) Business Days after request for payment, pay directly or reimburse each Purchaser Indemnified Party for any legal and other expenses incurred by such
Purchaser Indemnified Party in investigating or defending or preparing to defend against any such Liability. The Company also shall indemnify any Underwriter of the Registrable Securities, their officers, affiliates, directors, partners, members and
agents and each person who controls such Underwriters on substantially the same basis as that of the indemnification provided above in this Section 4.1. 
 The indemnity agreement contained in this Section 4.1 shall not apply to amounts paid in settlement of any such Liability if such settlement is effected without the consent of the Company (which consent
shall not be unreasonably withheld), nor shall the Company be liable to any holder of Registrable Securities included in any registration for any Liability to the extent that it arises solely from or is based solely upon and is in conformity with
information related to such holder furnished in writing by such holder expressly for use in connection with such registration, nor shall the Company be liable to any holder of Registrable Securities included in any registration for any Liability to
the extent it arises solely from or is based solely upon (i) any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement or prospectus relating to the Registrable Securities delivered in writing
by such holder after the Company had provided written notice to such holder that such Registration Statement or prospectus contained such untrue statement or alleged untrue statement of a material fact, or (ii) any omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading after the Company had provided written notice to such holder that such Registration Statement or prospectus contained such
omission or alleged omission. 
 4.2 Indemnification by Holders of Registrable
Securities. Each holder of Registrable Securities shall indemnify and hold harmless the Company, its officers, directors, partners, members and agents and each person, if any, who controls the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such holder, but solely with reference to information related to such holder furnished in writing by such holder expressly for
use in any Registration Statement or prospectus relating to Registrable Securities of such holder included in any registration, or any amendment or supplement thereto, or any preliminary prospectus. Each holder of Registrable Securities included in
any registration hereunder shall also indemnify and hold harmless any Underwriter of such holder’s Registrable Securities, their officers, directors, partners, members and agents and each person who controls such Underwriters on substantially
the same basis as that of the indemnification of the Company provided in this Section 4.2; provided, however, that in no event shall any indemnity obligation under this Section 4.2 exceed the dollar amount of
the net proceeds (after payment of any underwriting fees, discounts or commissions) actually received by such holder from the sale of Registrable Securities which gave rise to such indemnification obligation under such Registration Statement or
prospectus. 
  

 -14- 

 4.3 Conduct of Indemnification Proceedings. Promptly after receipt by any person of any notice of
any Liability in respect of which indemnity may be sought pursuant to Section 4.1 or 4.2, such person (the “Indemnified Party”) shall, if a claim in respect thereof is to be made against any other person for
indemnification hereunder, notify such other person (the “Indemnifying Party”) in writing of the Liability; provided, however, that the failure by the Indemnified Party to notify the Indemnifying Party shall not relieve the
Indemnifying Party from any liability which the Indemnifying Party may have to such Indemnified Party hereunder, except to the extent the Indemnifying Party is actually prejudiced by such failure. If the Indemnified Party is seeking indemnification
with respect to any claim or action brought against the Indemnified Party, then the Indemnifying Party shall be entitled to participate in such claim or action, and, to the extent that it wishes, jointly with all other Indemnifying Parties, to
assume the defense thereof with counsel satisfactory to the Indemnified Party. After notice from the Indemnifying Party to the Indemnified Party of its election to assume the defense of such claim or action, the Indemnifying Party shall not be
liable to the Indemnified Party for any legal or other expenses subsequently incurred by the Indemnified Party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that in any action in which
both the Indemnified Party and the Indemnifying Party are named as defendants, the Indemnified Party shall have the right to employ separate counsel (but no more than one such separate counsel) to represent the Indemnified Party and its controlling
persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the Indemnified Party against the Indemnifying Party, with the fees and expenses of such counsel to be paid by such Indemnifying Party if
representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, consent to entry of
judgment or effect any settlement of any claim or pending or threatened proceeding in respect of which the Indemnified Party is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such judgment
or settlement involves only the payment of money damages that are paid for by the Indemnifying Party and includes an unconditional release of such Indemnified Party from all Liability arising out of such claim or proceeding. 
 4.4 Contribution. If the indemnification provided for in the foregoing Sections 4.1, 4.2 and 4.3 is unavailable to any
Indemnified Party in respect of any Liability referred to herein, then each such Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such
Liability in such proportion as is appropriate to reflect the relative fault of the Indemnified Parties and the Indemnifying Parties in connection with the actions or omissions which resulted in such Liability, as well as any other relevant
equitable considerations. The relative fault of any Indemnified Party and any Indemnifying Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by such Indemnified Party or such Indemnifying Party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or
omission. 
  

 -15- 

 The parties hereto agree that it would not be just or equitable if contribution pursuant to this
Section 4.4 were determined by a pro rata allocation, or by any other method of allocation, that does not take account of the equitable considerations referred to in the immediately preceding paragraph. The amount paid or payable by an
Indemnified Party as a result of any Liability referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Party in connection
with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 4.4, no holder of Registrable Securities shall be required to contribute any amount in excess of the dollar amount of the net
proceeds (after payment of any underwriting fees, discounts or commissions) actually received by such holder from the sale of Registrable Securities which gave rise to such contribution obligation. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall he entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. 
 5. UNDERWRITING AND DISTRIBUTION. 
 5.1 Rule 144. The Company covenants that it shall file any
reports required to be filed by it under the Securities Act and the Exchange Act and shall take such further action as the holders of Registrable Securities may reasonably request, all to the extent required from time to time to enable such holders
to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 or Rule 144A under the Securities Act, as such Rules may be amended from time to time, or any similar Rule or
regulation hereafter adopted by the SEC. 
 5.2 Restrictions on Sale by the Company and Others. The Company agrees (i) not to
effect any sale or distribution of any securities similar to those being registered in accordance with Section 2.1, or any securities convertible into or exchangeable or exercisable for such securities, during the 90 days prior to, and
during the 180-day period beginning on, the effective date of any Demand Registration (except as part of such Demand Registration to the extent permitted by Section 2.1(d)); and (ii) that any agreement entered into after the date
hereof, pursuant to which the Company issues or agrees to issue any privately placed securities shall contain a provision under which holders of such securities agree not to effect any sale or distribution of any such securities during the periods
described in (i) above, in each case including a sale pursuant to Rule 144 or 144A under the Securities Act (except as part of any such registration, if permitted); provided, however, that the provisions of this Section 5.2
shall not prevent the conversion or exchange of any securities pursuant to their terms into or for other securities and shall not prevent the issuance of securities by the Company under any employee benefit, stock option or stock subscription plans.

 6. MISCELLANEOUS. 
 6.1 Other
Registration Rights. The Company represents and warrants that, except as provided in Schedule 6.1 hereto, no Person has any right to require the Company to register any shares of the Company’s Capital Stock for sale or to include
shares of the Company’s Capital Stock in any registration filed by the Company for the sale of shares of Capital Stock for its own account or for the account of any other Person. From and after the date hereof, the Company shall not, without
the prior written consent of Purchaser, (i) enter into any agreement granting 

  

 -16- 

 
any demand registration right (i.e., the right to require the Company to register the sale of any shares of the Company’s Capital Stock) that is
inconsistent with, equal to or superior to the rights granted to the holders of Registrable Securities hereunder or that otherwise adversely affect the registration rights granted to the holders of Registrable Securities hereunder, (ii) enter
into any agreement granting any piggy-back registration right (i.e., the right to require the Company to register the sale of any shares of the Company’s Capital Stock in any registration filed by the Company for the sale of shares of
Capital Stock for its own account or for the account of any other Person) which is inconsistent with, equal to or superior to any registration rights granted hereunder, or (iii) amend any agreement set forth Schedule 6.1 hereto so as to
cause the registration rights granted therein to be inconsistent with, equal to or superior to the rights granted to the holders of Registrable Securities hereunder or to otherwise adversely affect the registration rights granted to the holders of
Registrable Securities hereunder. 
 6.2 Notices. All notices, demands and other communications to be given hereunder shall be made in
writing and shall be by registered or certified first class mail, return receipt requested, facsimile (with receipt confirmed), a recognized overnight delivery service, courier service, email or personal delivery. All such notices and communications
shall be deemed to have been duly given (as applicable) when delivered by hand, if personally delivered; when delivered by courier; when delivered by commercial overnight delivery service; if mailed via United States Postal Service, five
(5) Business Days after being deposited in the mail, postage prepaid; if delivered by facsimile, when receipt is acknowledged, or if delivered by email, upon confirmed transmission. All communications to the Company and Purchaser shall be sent
to their respective addresses as set forth in the Purchase Agreement. 
 6.3 Successors and Assigns. 
 (a) All the covenants and provisions of this Agreement shall bind and inure to the benefit of the parties’ respective successors and assigns
hereunder. The rights and obligations of Purchaser under this Agreement shall be freely assignable in whole or in part. Each such assignee, by accepting such assignment of the rights of the assignor hereunder shall be deemed to have agreed to and be
bound by the obligations of the assignor hereunder. The rights and obligations of the Company hereunder may not be assigned and any such purported assignment by the Company shall be void and of no effect. 
 (b) In the event of a transfer of Registrable Securities, the rights applicable to the holders of such Registrable Securities hereunder shall be
automatically assigned with the transfer of such Registrable Securities only in the event of a transfer of not less than 50% of the Registrable Securities originally issued to such person, and immediately upon such a transfer, the rights of the
transferor under this Agreement shall cease and be of no further effect with respect to the Registrable Securities transferred. A transfer of Registrable Securities under this subsection shall include any transfer by means of sale, pledge,
hypothecation, hedge, put or call option, straddle or collar, or any similar transaction respecting such Registrable Securities. 
 6.4
Benefits of this Agreement. This Agreement shall be for the sole and exclusive benefit of Purchaser and its permitted successors and assigns. There are no intended third party beneficiaries of this Agreement. 
  

 -17- 

 6.5 Governing Law. In all respects, including matters of construction, validity and performance,
this Agreement shall be governed by, and construed and enforced in accordance with, the internal laws of the State of California applicable to contracts made and performed in that state (without regard to the choice of law or conflicts of law
provisions thereof); provided, however, that notwithstanding the foregoing election of California law to govern this Agreement, the Company is a Nevada corporation, and subject in all respects to the Nevada law relating to the law of
corporations, as they may be in force and effect from time to time (including, without limitation, Chapter 78 of the Nevada Revised Statutes). 
 6.6 Arbitration. All disputes arising under this Agreement shall be settled by binding arbitration; provided, however, that this Section shall not preclude any party from seeking equitable relief in a court of competent
jurisdiction. Arbitration shall be held in Los Angeles, California under the auspices of the American Arbitration Association (the “AAA”) pursuant to the Commercial Arbitration Rules of the AAA, and shall be by one
arbitrator, independent of the parties to this Agreement, selected from a list provided by the AAA in accordance with such Commercial Arbitration Rules. The arbitrator shall make his or her decision in writing within thirty (30) days after the
close of the arbitration hearing. To the maximum extent permitted by law, the decision of the arbitrator shall be final and binding and not be subject to appeal. If a party against whom the arbitrator renders an award fails to abide by such award,
the other party or parties may seek to enforce such award in a court of competent jurisdiction. The fees and expenses of the arbitration (including reasonable attorneys’ fees, costs and expenses) or any action to enforce an arbitration award
shall be awarded to the prevailing party or parties in such arbitration. 
 6.7 Jurisdiction, Venue, Etc. IN ANY ACTION SEEKING
EQUITABLE RELIEF, TO ENFORCE ARBITRATION OR AN ARBITRAL AWARD, OR IN THE EVENT THAT ARBITRATION CANNOT BE ENFORCED, EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY: 
 (a) SUBMITS FOR ITSELF AND ITS PROPERTY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT, OR FOR RECOGNITION AND ENFORCEMENT OF ANY JUDGMENT IN RESPECT THEREOF, TO THE GENERAL JURISDICTION OF THE COURTS OF
THE STATE OF CALIFORNIA LOCATED IN THE CITY OF LOS ANGELES, THE COURTS OF THE UNITED STATES OF AMERICA FOR THE CENTRAL DISTRICT OF CALIFORNIA, AND THEIR RESPECTIVE APPELLATE COURTS; 
 (b) CONSENTS THAT ANY SUCH ACTION OR PROCEEDING MAY BE BROUGHT IN SUCH COURTS AND WAIVES ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE VENUE OF
ANY SUCH ACTION OR PROCEEDING IN ANY SUCH COURT OR THAT SUCH ACTION OR PROCEEDING WAS BROUGHT IN AN INCONVENIENT COURT AND AGREES NOT TO PLEAD OR CLAIM THE SAME OR TO SEEK TRANSFER TO ANOTHER JUDICIAL DISTRICT; 
 (c) AGREES THAT SERVICE OF PROCESS IN ANY SUCH ACTION OR PROCEEDING MAY BE EFFECTED BY MAILING A COPY THEREOF BY REGISTERED OR CERTIFIED MAIL, RETURN
RECEIPT REQUESTED (OR ANY SUBSTANTIALLY 

  

 -18- 

 
SIMILAR FORM OF MAIL), POSTAGE PREPAID, TO AN OFFICER, DIRECTOR, MANAGING AGENT OR OTHER AUTHORIZED PERSON OF SUCH PARTY AT SUCH PARTY’S ADDRESS SET
FORTH IN THE PURCHASE AGREEMENT; AGREES THAT NOTHING HEREIN SHALL AFFECT THE RIGHT TO EFFECT SERVICE OF PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR SHALL LIMIT THE RIGHT TO SUE IN ANY OTHER JURISDICTION; 
 (d) WAIVES, TO THE MAXIMUM EXTENT NOT PROHIBITED BY LAW, TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT AND FOR ANY
COUNTERCLAIM THEREIN; AND 
 (e) AGREES, THAT IF ANY ACTION OR PROCEEDING IS FILED IN A COURT OF THE STATE OF CALIFORNIA BY OR AGAINST ANY
PARTY HERETO IN CONNECTION WITH ANY OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, (I) THE COURT SHALL, AND IS HEREBY DIRECTED TO, MAKE A GENERAL REFERENCE PURSUANT TO CALIFORNIA CODE OF CIVIL PROCEDURE SECTION 638 TO A SINGLE REFEREE (WHO
SHALL BE A SINGLE ACTIVE OR RETIRED JUDGE) TO HEAR AND DETERMINE ALL OF THE ISSUES IN SUCH ACTION OR PROCEEDING (WHETHER OF FACT OR OF LAW) AND TO REPORT A STATEMENT OF DECISION, PROVIDED THAT AT THE OPTION OF ANY PARTY TO SUCH PROCEEDING, ANY SUCH
ISSUES PERTAINING TO A “PROVISIONAL REMEDY” AS DEFINED IN CALIFORNIA CODE OF CIVIL PROCEDURE SECTION 1281.8 SHALL BE HEARD AND DETERMINED BY THE COURT, AND (II) COMPANY SHALL BE SOLELY RESPONSIBLE TO PAY ALL FEES AND EXPENSES OF ANY
REFEREE APPOINTED IN SUCH ACTION OR PROCEEDING. 
 6.8 Prevailing Party; Attorney’s Fees. If any party hereto commences any
action against any other party hereto with respect to the enforcement or interpretation of this Agreement, then the prevailing party in such action shall be entitled to an award of its costs of litigation, including reasonable attorneys’ fees.

 6.9 Acknowledgments. Each of the parties hereby acknowledges that: 
 (a) such party has been advised by counsel in the negotiation, execution and delivery of this Agreement; and 
 (b) Purchaser has no fiduciary relationship with or duty to the Company arising out of or in connection with this Agreement. 
 6.10 No Strict Construction. No party, nor its counsel, shall be deemed the drafter of this Agreement for purposes of construing the provisions of
this Agreement, and all provisions of this Agreement shall be construed in accordance with their fair meaning, and not strictly for or against any party. 
 6.11 Headings. The title of and the section and paragraph headings in this Agreement are for convenience of reference only and shall not govern or affect the interpretation of any of the terms or provisions of
this Agreement. 
  

 -19- 

 6.12 Severability. If any one or more of the provisions contained in this Agreement, or the
application thereof in any circumstance, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions hereof shall not
be in any way impaired, unless the provisions held invalid, illegal or unenforceable shall substantially impair the benefits of the remaining provisions of this Agreement. The parties hereto further agree to replace such invalid, illegal or
unenforceable provision of this Agreement with a valid, legal and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid, illegal or unenforceable provision. 
 6.13 Further Assurances. Each of the parties hereto shall execute such documents and perform such further acts (including, without limitation,
obtaining any consents, exemptions, authorizations, or other actions by, or giving any notices to, or making any filings with, any Governmental Authority or any other Person) as may be reasonably required or desirable to carry out or to perform the
provisions of this Agreement. 
 6.14 Amendment and Waiver. No failure or delay on the part of any of the parties hereto in exercising
any right, power or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power or remedy.
The remedies provided for in this Agreement are cumulative and are not exclusive of any remedies that may be available to the parties hereto at law, in equity or otherwise. Any amendment, supplement or modification of or to any provision of this
Agreement, any waiver of any provision of this Agreement, and any consent to any departure by any party from the terms of any provision of this Agreement, shall be effective (i) only if it is made or given in writing and signed by all of the
parties hereto, and (ii) only in the specific instance and for the specific purpose for which it is made or given. No amendment, supplement or modification of or to any provision of this Agreement, or any waiver of any such provision or consent
to any departure by any party from the terms of any such provision may be made orally. 
 6.15 Counterparts. This Agreement may be
executed in any number of counterparts (including by facsimile or email scan with attachment) and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same
instrument. 
 6.16 Time of Essence. With regards to all dates and time periods set forth or referred to in this Agreement, time is of
the essence. 
 6.17 Entire Agreement. This Agreement and the other Transaction Documents (together with the exhibits and schedules
hereto and thereto), is intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein
and therein. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein or therein. This Agreement, together with the exhibits and schedules hereto, and the other Transaction Documents supersede
all prior agreements and understandings between the parties with respect to such subject matter. 
  

 -20- 

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 -21- 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date first set forth
above. 
  

			
	PURCHASER:
	
	BISON CAPITAL EQUITY PARTNERS II-A, L.P.
		
	By:	 	BISON CAPITAL PARTNERS II, LLC, its
	general partner
		
	By:	 	 /s/ Douglas B. Trussler

	Name:	 	Douglas B. Trussler
	Title:	 	Managing Member
	
	BISON CAPITAL EQUITY PARTNERS II-B, L.P.
		
	By:	 	BISON CAPITAL PARTNERS II, LLC, its
	general partner
		
	By:	 	 /s/ Douglas B. Trussler

	Name:	 	Douglas B. Trussler
	Title:	 	Managing Member
	
	COMPANY:
	
	THE CENTER FOR WOUND HEALING, INC.
		
	By:	 	 /s/ Andrew G. Barnett

	Name:	 	Andrew G. Barnett
	Title:	 	Chief Financial Officer

 Signature Page to Registration Rights Agreement 

 Schedule 6.1 
 Other Registration Rights Agreements 
 Registration Rights Agreement dated as of April 7, 2006 by and among the
Company, DKR SoundShore Oasis Holding Fund, Ltd. and Harborview Master Fund LP. 
  

 -23-Form of Voting Agreement

 Exhibit 4.7 
 VOTING AGREEMENT 
 THIS VOTING
AGREEMENT (this “Agreement”) is made as of March 31, 2008, by and among BISON CAPITAL EQUITY PARTNERS II-A, L.P., a Delaware limited partnership, and BISON CAPITAL EQUITY
PARTNERS II-B, L.P., a Delaware limited partnership (collectively, “Purchaser”), THE CENTER FOR WOUND HEALING, INC., a Nevada corporation (the “Company”), and the undersigned stockholders of
the Company (the “Stockholders”). Each capitalized term used herein and not otherwise defined shall have the meaning given to it in that certain Securities Purchase Agreement, dated as of even date herewith, by and between
the Company and Purchaser (the “Purchase Agreement”). 
 RECITALS 
 WHEREAS, pursuant to the Purchase Agreement, the Company has agreed, among other things, to sell a note in the principal amount of $20,000,000
(the “Note”) to Purchaser and issue to Purchaser warrants to purchase common stock of the Company to Purchaser (collectively the “Warrant”); 
 WHEREAS, Purchaser, as a condition precedent to entering into the Purchase Agreement and the consummation of the transactions contemplated
thereby, has required that the parties hereto enter into this Agreement. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows: 
 1. Board of Directors of the Company. 
 (a) At each election of directors of the Company during the term of this Agreement, or upon the earlier death, resignation or removal of a director,
whether by meeting of the Company’s stockholders or by written consent of such stockholders, the Stockholders shall cast in favor of the following persons the number of votes represented by all equity interests in the Company having voting
rights now owned or hereafter acquired by them (such owned or after-acquired equity interests, the “Interests”) in order to elect the Bison Representatives (as defined below) as directors. In furtherance of the foregoing, the
Company and the Stockholders agree to promptly hereafter hold a meeting or act by written consent for the purpose of electing the Bison Representatives as directors. 
 (b) The “Bison Representatives” shall initially be Louis N. Caballero and Douglas B. Trussler. At such time, if any, as either Bison Representative is unable to serve as a director, the Bison
Representatives shall be such persons as shall be designated from time to time by Purchaser. 
 (c) Upon the occurrence of (i) an Event
of Default (as defined in the Purchase Agreement) under Section 10.1(d) of the Purchase Agreement, (ii) any other non-monetary Event of Default that remains uncured (if capable of being cured, it being understood that no cure period
will apply if such Event of Default is incapable of being cured) for more than ten (10) Business Days, or (iii) any monetary Event of Default that remains uncured for more than 

  

 -1- 

 
two (2) Business Days, and (with respect to each of the foregoing clauses (i) through (iii)) until such Event of Default is no longer existing,
Purchaser shall have the right to appoint a majority of the members of the Board of Directors. In furtherance of the foregoing, upon the written demand by Purchaser, the Stockholders agree to hold a meeting or act by written consent to remove such
number of existing directors (other than the Bison Representatives) as is necessary, and to cast the number of votes represented by all Interests in favor of persons designated by Purchaser at such time to replace such removed directors (such
replacement directors and the Bison Representatives are collectively referred to as the “Bison Default Representatives”), in order that Purchaser will have designated at least a majority of the members of the Board of
Directors. 
 (d) The number of authorized directors of the Company shall at no time exceed seven (7) without the written consent of
Purchaser. 
 (e) The Company shall at all times maintain directors’ and officers’ liability insurance coverage for the Bison
Representatives and the Bison Default Representatives in amounts adequate and customary for similarly situated public companies (and in no event less favorable to the Bison Representatives and the Bison Default Representatives than any other
director). The Company shall promptly reimburse or advance all costs related to board attendance (including, without limitation, business class airfare and hotel accommodations) or the discharge of board duties incurred by the Bison Representatives
and the Bison Default Representatives. 
 (f) If required of the all of the other directors, each of the Bison Representatives and, if
applicable, the Bison Default Representatives shall complete a questionnaire, in substantially the form attached hereto as Exhibit A (as may be modified or replaced from time to time, the “Questionnaire”), prior to
each election of directors of the Company during the term of this Agreement, or upon the death, resignation or removal of a director. 
 2. Removal and Replacement. 
 (a) In the event that Purchaser determines to remove from office any of the then elected
Bison Representatives or Bison Default Representatives, as the case may be, each of the Stockholders or the Company, shall take all actions necessary and appropriate to cause such removal to be effected promptly. 
 (b) In the event of removal, resignation, incapacity or death of any then Bison Representatives or Bison Default Representatives, the Stockholders or the
Company, as the case may be, shall take all actions necessary and appropriate to cause the successor Bison Representatives or Bison Default Representatives to be elected as directors. 
 (c) The Stockholders or the Company, as the case may be, shall not vote their Interests to remove any director in contravention of any provision of this
Agreement; provided, however, that the foregoing shall not preclude the removal of a director for cause. 
 3. No
Liability for Election of Recommended Director. Neither the Company, Purchaser nor any Stockholder, nor any officer, director, stockholder, partner, employee or agent of such party, makes any representation or warranty as to the fitness or
competence of the Bison Representatives or the Bison Default Representatives to serve as a director by virtue of such party’s execution of this Agreement or by the act of such party in voting for the Bison Representatives or the Bison Default
Representatives pursuant to this Agreement or otherwise. 
  

 2 

 4. Grant of Irrevocable Proxy. Concurrently with the execution of this Agreement, each
Stockholder agrees to deliver to Purchaser a duly executed Irrevocable Proxy and Power of Attorney substantially in the form attached hereto as Exhibit B (the “Proxy”), which shall be irrevocable during the term
of this Agreement to the fullest extent permissible by law, with respect to the Interests. Each Stockholder expressly acknowledges that such Proxy is coupled with an interest. Each Stockholder hereby revokes any and all prior proxies, powers of
attorney or similar authorizations with respect to the Interests to the extent related to the election of directors of the Company or otherwise related to this Agreement. 
 5. Manner of Voting. The voting of Interests pursuant to this Agreement may be effected in person, by proxy, by written consent or in any other manner permitted by applicable law. 
 6. Legending of Certificates. If so requested by Purchaser, each Stockholder agrees that the certificates representing the Interests shall
bear a legend stating that they are subject to this Agreement and to an irrevocable proxy. Subject to the terms of Section 8, each Stockholder agrees that it shall not transfer any Interests without first having the aforementioned legend
affixed to the certificates representing the Interests. 
 7. Splits, Dividends, etc. In the event of any transaction involving
the issuance of securities or other equity interests to the Stockholders with respect to or in replacement of their existing holdings of the Company’s equity, the securities or other interests so issued shall be subject to this Agreement and
shall be deemed to be incorporated into the provisions hereof and shall be endorsed with the legend set forth in Section 6. 
 8.
Assignment, Binding Effect. 
 (a) Except with respect to transfers of Interests in a public sale pursuant to Rule 144 (or any
successor thereto) under the Securities Act of 1933, the Stockholders hereby agree, and any transferee or assignee of any Interests is hereby on notice, that any transfer or assignment of such Interests is conditioned upon such transferee’s or
assignee’s execution and delivery to the parties of a Proxy and a joinder agreement in the form of Exhibit C prior to such transfer or assignment. Any transfer or assignment of any such Interests in violation of this
Section 8(a) shall be void and be of no force or effect. All parties hereby agree that, in the event of a transfer of Interests in a public sale pursuant to Rule 144 (or any successor thereto) under the Securities Act of 1933, as
amended, the legend referenced in Section 6 hereto shall be removed and this Agreement shall act as authority for the transfer agent to remove such legend in conjunction with the removal of the Securities Act legend pursuant to Rule 144
(or any successor thereto) under the Securities Act of 1933, as amended. In addition, each Stockholder agrees to notify Purchaser of the change in such Stockholder’s Interest and, if requested by Purchaser, execute an amended proxy to reflect
the number of shares of capital stock owned directly or beneficially by the Stockholder following the transfer of Interests referenced above. 
 (b) The Company hereby agrees, and any person acquiring any shares of the Company’s capital stock from the Company is hereby on notice, that any issuance of such securities is conditioned upon such person’s execution and delivery
to the parties of a Proxy and a joinder agreement in the form of Exhibit C prior to such issuance. Any issuance of any such securities of the Company in violation of this Section 8(b) shall be void and be of no force or effect.

  

 3 

 9. Term of Agreement. This Agreement shall continue in effect so long as either the Note or
Warrant remains outstanding. 
 10. Company Obligations. The Company agrees to use its best efforts to ensure that the rights
granted to Purchaser hereunder are effective and that Purchaser enjoys the benefits thereof. Such actions include, without limitation, the use of the Company’s best efforts to cause the nomination and election of the Bison Representatives or
the Bison Default Representatives as directors as provided in Sections 1 and 2. The Company will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be performed hereunder by
the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Agreement and in the taking of all such actions as may be necessary or appropriate in order to protect the rights of Purchaser hereunder
against impairment. 
 11. Monitoring Rights. In each calendar month after the Closing Date, the Company shall cause its
Representatives to meet with Representatives of Purchaser to review the financial condition of the Credit Parties as reflected in the financial information furnished pursuant to Sections 8.3 and 8.4 of the Purchase Agreement. Each
meeting shall at all times be composed of at least Andrew Barnett and David Walz (or their successors) and two (2) individuals designated by Purchaser (who initially shall be Douglas B. Trussler and Louis N. Caballero). The financial officers
and other members of senior management of the Company shall be available at each meeting to review financial information and discuss other matters. Purchaser and the Company shall mutually agree in each calendar month on the date and time for the
meeting to be held in the immediately succeeding calendar month; provided, that the failure to agree on such date and time in any month shall not be construed as an agreement not to hold a meeting in the immediately succeeding month. Meetings
may be conducted by telephone so long as each of the persons attending can hear each of the other persons attending the meeting. 
 12. Articles and Bylaws. 
 (a) Attendance at Stockholder Meeting. Each Stockholder agrees to appear, or cause
the holder of record (the “Record Holder”) of any Interests on any applicable record date (“Record Date”) to appear, in person or by proxy, for purpose of obtaining a quorum at any annual or special
meeting of the Company’s stockholders (a “Meeting”), called for the purpose of approving (i) amending and restating the Company’s current articles of incorporation (the “Current
Articles”) such that any director may be removed with only the affirmative vote of the holders of a majority of the outstanding voting stock (without any requirement that the removal be for cause), (ii) amending and restating the
Current Articles in order to clarify any ambiguities in the corporate records of the Company, (iii) amending and restating the Company’s current bylaws (the “Current Bylaws”) to match the Current Articles, which do
not allow for actions by written consent, and (iv) amending the bylaws and articles of the Company in the event that any of the rights of Purchaser hereunder are not enforceable by Purchaser due to the articles or bylaws of the Company (the
matters in the immediately foregoing clauses (i) through (iv), the “Amendments”). The Amendments shall be in a form reasonably approved by Purchaser. The Company covenants to cause Meetings to be held for the purpose of
approving the Amendments. 
 (b) Voting. Each Stockholder hereby agrees that at any Meeting called for the purpose of approving the
Amendments, however called (and in any action by written consent of the Company’s stockholders, if applicable), the Stockholders shall vote, or cause the Record 

  

 4 

 
Holder to vote, the Interests (and any other voting interests of the Company directly or indirectly owned beneficially or of record by such Stockholder on
the Record Date set for such Meeting), in person or by proxy, in favor of the Amendments. 
 13. Representations. 

(a) Authority. Each Stockholder has all necessary power and authority to execute and deliver this Agreement, to perform such Stockholder’s
obligations hereunder and to consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by such Stockholder and constitutes a legal, valid and binding obligation of such Stockholder, enforceable against such
Stockholder Holder in accordance with its terms. 
 (b) Title to the Interests. As of the date hereof, each Stockholder is the
beneficial owner of the Interests set forth opposite such Stockholder’s name on Exhibit F attached hereto, such Interests are owned free and clear of all security interests, liens, claims, pledges, options, rights of first refusal,
agreements, limitations on such Stockholder’s voting rights, charges and other encumbrances of any nature whatsoever, and such Stockholder has not appointed or granted any proxy, which appointment or grant is still effective, with respect to
the Interests owned by such Stockholder. 
 14. Notices. All notices, demands and other communications to be given
hereunder shall be made in writing and shall be by registered or certified first class mail, return receipt requested, facsimile (with receipt confirmed), a recognized overnight delivery service, courier service, email or personal delivery. All such
notices and communications shall be deemed to have been duly given (as applicable) when delivered by hand, if personally delivered; when delivered by courier; when delivered by commercial overnight delivery service; if mailed via United States
Postal Service, five (5) Business Days after being deposited in the mail, postage prepaid; if delivered by facsimile, when receipt is acknowledged, or if delivered by email, upon confirmed transmission. All communications shall be sent to the
parties to be notified at their respective addresses, (i) in the case of the Company, Purchaser and the initial Stockholders, set forth on Exhibit G, and (ii) in the case of any subsequent holder of shares of the Company, in the
joinder agreement to be executed pursuant to Section 8; or to such other address as such party may designate by ten (10) days’ advance written notice to the other parties hereto. 
 15. Successors and Assigns. All of the covenants and provisions of this Agreement shall bind and inure to the benefit of the parties’
respective successors and assigns hereunder. Subject to applicable securities laws, Purchaser may assign any of its rights hereunder. None of the Stockholders or the Company may assign any of its rights, or delegate any of its obligations, under
this Agreement without the prior written consent of Purchaser (in its sole discretion), and any such purported assignment without the written consent of Purchaser shall be void and of no effect. 
 16. Benefits of this Agreement. This Agreement shall be for the sole and exclusive benefit of Purchaser and its permitted successors
and assigns. There are no intended third party beneficiaries of this Agreement. 
 17. Governing Law. In all respects,
including matters of construction, validity and performance, this Agreement shall be governed by, and construed and enforced in accordance with, the internal laws of the State of California applicable to contracts made and performed in that state
(without regard to the choice of law or conflicts of law provisions thereof); provided, however, that notwithstanding the foregoing election of California law to govern this Agreement, 

  

 5 

 
the Company is a Nevada corporation, and subject in all respects to the Nevada law relating to the law of corporations, as they may be in force and effect
from time to time (including, without limitation, Chapter 78 of the Nevada Revised Statutes). 
 18. Arbitration. All disputes
arising under this Agreement shall be settled by binding arbitration; provided, however, that this Section shall not preclude any party from seeking equitable relief in a court of competent jurisdiction. Arbitration shall be held in
Los Angeles, California under the auspices of the American Arbitration Association (the “AAA”) pursuant to the Commercial Arbitration Rules of the AAA, and shall be by one arbitrator, independent of the parties to this
Agreement, selected from a list provided by the AAA in accordance with such Commercial Arbitration Rules. The arbitrator shall make his or her decision in writing within thirty (30) days after the close of the arbitration hearing. To the
maximum extent permitted by law, the decision of the arbitrator shall be final and binding and not be subject to appeal. If a party against whom the arbitrator renders an award fails to abide by such award, the other party or parties may seek to
enforce such award in a court of competent jurisdiction. The fees and expenses of the arbitration (including reasonable attorneys’ fees, costs and expenses) or any action to enforce an arbitration award shall be awarded to the prevailing party
or parties in such arbitration. 
 19. Jurisdiction, Venue, Etc. IN ANY ACTION SEEKING EQUITABLE RELIEF, TO ENFORCE
ARBITRATION OR AN ARBITRAL AWARD, OR IN THE EVENT THAT ARBITRATION CANNOT BE ENFORCED, EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY: 
 (a) SUBMITS FOR ITSELF AND ITS PROPERTY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT, OR FOR RECOGNITION AND ENFORCEMENT OF ANY JUDGMENT IN RESPECT THEREOF, TO THE GENERAL JURISDICTION OF THE COURTS OF THE STATE OF
CALIFORNIA LOCATED IN THE CITY OF LOS ANGELES, THE COURTS OF THE UNITED STATES OF AMERICA FOR THE CENTRAL DISTRICT OF CALIFORNIA, AND THEIR RESPECTIVE APPELLATE COURTS; 
 (b) CONSENTS THAT ANY SUCH ACTION OR PROCEEDING MAY BE BROUGHT IN SUCH COURTS AND WAIVES ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE VENUE OF ANY SUCH ACTION OR PROCEEDING IN ANY SUCH COURT OR THAT SUCH
ACTION OR PROCEEDING WAS BROUGHT IN AN INCONVENIENT COURT AND AGREES NOT TO PLEAD OR CLAIM THE SAME OR TO SEEK TRANSFER TO ANOTHER JUDICIAL DISTRICT; 
 (c) AGREES THAT SERVICE OF PROCESS IN ANY SUCH ACTION OR PROCEEDING MAY BE EFFECTED BY MAILING A COPY THEREOF BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED (OR ANY SUBSTANTIALLY SIMILAR FORM OF MAIL),
POSTAGE PREPAID, TO AN OFFICER, DIRECTOR, MANAGING AGENT OR OTHER AUTHORIZED PERSON OF SUCH PARTY AT SUCH PARTY’S ADDRESS SET FORTH IN THE PURCHASE AGREEMENT; AGREES THAT NOTHING HEREIN SHALL AFFECT THE RIGHT TO EFFECT SERVICE OF PROCESS IN ANY
OTHER MANNER PERMITTED BY LAW OR SHALL LIMIT THE RIGHT TO SUE IN ANY OTHER JURISDICTION; 
  

 6 

 (d) WAIVES, TO THE MAXIMUM EXTENT NOT PROHIBITED BY LAW, TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING
RELATING TO THIS AGREEMENT AND FOR ANY COUNTERCLAIM THEREIN; AND 
 (e) AGREES, THAT IF ANY ACTION OR PROCEEDING IS FILED IN A COURT OF THE
STATE OF CALIFORNIA BY OR AGAINST ANY PARTY HERETO IN CONNECTION WITH ANY OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, (I) THE COURT SHALL, AND IS HEREBY DIRECTED TO, MAKE A GENERAL REFERENCE PURSUANT TO CALIFORNIA CODE OF CIVIL
PROCEDURE SECTION 638 TO A SINGLE REFEREE (WHO SHALL BE A SINGLE ACTIVE OR RETIRED JUDGE) TO HEAR AND DETERMINE ALL OF THE ISSUES IN SUCH ACTION OR PROCEEDING (WHETHER OF FACT OR OF LAW) AND TO REPORT A STATEMENT OF DECISION, PROVIDED THAT AT
THE OPTION OF ANY PARTY TO SUCH PROCEEDING, ANY SUCH ISSUES PERTAINING TO A “PROVISIONAL REMEDY” AS DEFINED IN CALIFORNIA CODE OF CIVIL PROCEDURE SECTION 1281.8 SHALL BE HEARD AND DETERMINED BY THE COURT, AND (II) THE FEES AND
EXPENSES OF ANY REFEREE APPOINTED IN SUCH ACTION OR PROCEEDING SHALL BE AWARDED TO THE PREVAILING PARTY OR PARTIES IN SUCH ACTION OR PROCEEDING. 
 20. Prevailing Party; Attorney’s Fees. If any party hereto commences any action against any other party hereto with respect to the enforcement or interpretation of this Agreement, then the prevailing party in such action
shall be entitled to an award of its costs of litigation, including reasonable attorneys’ fees. 
 21. Specific
Enforcement. It is agreed and understood that monetary damages would not adequately compensate an injured party for the breach of this Agreement by any other party, that this Agreement shall be specifically enforceable, and that any breach or
threatened breach of this Agreement shall be the proper subject of a temporary or permanent injunction or restraining order. Further, each party hereby waives any claim or defense that there is an adequate remedy at law for such breach or threatened
breach. 
 22. Acknowledgments. Each of the parties hereby acknowledges that: 
 (a) such party has been advised by counsel in the negotiation, execution and delivery of this Agreement; and 
 (b) Purchaser has no fiduciary relationship with or duty to any of the parties hereto arising out of or in connection with this Agreement. 
 23. No Strict Construction. No party, nor its counsel, shall be deemed the drafter of this Agreement for purposes of construing the
provisions of this Agreement, and all provisions of this Agreement shall be construed in accordance with their fair meaning, and not strictly for or against any party. 
 24. Headings. The title of and the section and paragraph headings in this Agreement are for convenience of reference only and shall not govern or affect the interpretation of any of the terms or
provisions of this Agreement. 
 25. Severability. If any one or more of the provisions contained in this Agreement, or
the application thereof in any circumstance, is held invalid, illegal or unenforceable in any 

  

 7 

 
respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions hereof shall
not be in any way impaired, unless the provisions held invalid, illegal or unenforceable shall substantially impair the benefits of the remaining provisions of this Agreement. The parties hereto further agree to replace such invalid, illegal or
unenforceable provision of this Agreement with a valid, legal and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid, illegal or unenforceable provision. 
 26. Further Assurances. Each of the parties hereto shall execute such documents and perform such further acts (including, without
limitation, obtaining any consents, exemptions, authorizations, or other actions by, or giving any notices to, or making any filings with, any Governmental Authority or any other Person) as may be reasonably required or desirable to carry out or to
perform the provisions of this Agreement. 
 27. Amendment and Waiver. No failure or delay on the part of any of the parties
hereto in exercising any right, power or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any other
right, power or remedy. The remedies provided for in this Agreement are cumulative and are not exclusive of any remedies that may be available to the parties hereto at law, in equity or otherwise. Any amendment, supplement or modification of or to
any provision of this Agreement, any waiver of any provision of this Agreement, and any consent to any departure by any party from the terms of any provision of this Agreement, shall be effective (i) only if it is made or given in writing and
signed by the Company, the Purchaser and the Stockholder(s) that hold(s) a majority of the Interests, and (ii) only in the specific instance and for the specific purpose for which it is made or given. No amendment, supplement or modification of
or to any provision of this Agreement, or any waiver of any such provision or consent to any departure by any party from the terms of any such provision may be made orally. 
 28. Counterparts. This Agreement may be executed in any number of counterparts (including by facsimile or email scan with
attachment) and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 
 29. Time of Essence. With regards to all dates and time periods set forth or referred to in this Agreement, time is of the essence.

 30. Entire Agreement. As among the Stockholders and Purchaser, this Agreement contains the entire understanding of such
parties with respect to its subject matter, and all prior negotiations, discussions, commitments and understandings heretofore had between them with respect thereto are superseded. As between Purchaser and the Company, this Agreement and the other
transaction documents referenced in the Purchase Agreement contain the entire understanding of such parties with respect to its subject matter, and all prior negotiations, discussions, commitments and understandings heretofore had between them with
respect thereto are superseded. 
 [Signatures appear on following pages] 
  

 8 

 IN WITNESS WHEREOF, this Voting Agreement has been executed by the parties hereto as of the day and year
first above written. 
  

			
	COMPANY:
	
	THE CENTER FOR WOULD HEALING, INC.
		
	By:	 	 /s/ Andrew G. Barnett

	Name:	 	Andrew G. Barnett
	Title:	 	CEO
	
	STOCKHOLDERS:
		
	By:	 	  

	Name:	 	John Capotorto
		
	By:	 	  

	Name:	 	Phillip Forman
		
	By:	 	  

	Name:	 	David J. Walz
		
	By:	 	  

	Name:	 	The Elise Trust, [FIRST ROCK TRUSTEES LTD] as Trustee
		
	By:	 	  

	Name:	 	John DeNobile
		
	By:	 	  

	Name:	 	Gary Rodgers
		
	By:	 	  

	Name:	 	Paul Basmasjian
		
	By:	 	  

	Name:	 	David H. Meyrowitz

  

 -9- 

 IN WITNESS WHEREOF, this Voting Agreement has been executed by the parties hereto as of the day and year
first above written. 
  

			
	COMPANY:
	
	THE CENTER FOR WOULD HEALING, INC.
		
	By:	 	 /s/ Andrew G. Barnett

	Name:	 	Andrew G. Barnett
	Title:	 	Chief Financial Officer
	
	STOCKHOLDERS:
		
	By:	 	 /s/ John Capotorto

	Name:	 	John Capotorto
		
	By:	 	 /s/ Phillip Forman

	Name:	 	Phillip Forman
		
	By:	 	 /s/ David J. Walz

	Name:	 	David J. Walz
		
	By:	 	 /s/ Andrew Barnett

	Name:	 	Andrew Barnett
		
	By:	 	  

	Name:	 	The Elise Trust, First Rock Trustees, as Trustee
		
	By:	 	 /s/ Paul Basmasjian

	Name:	 	Paul Basmasjian
		
	By:	 	 /s/ David H. Meyrowitz

	Name:	 	David H. Meyrowitz

 Signature Page to Voting Agreement 
  

 - 10 - 

			
	PURCHASER:
	
	BISON CAPITAL EQUITY PARTNERS II-A, L.P.
	
	By: BISON CAPITAL PARTNERS II, LLC, its general partner
		
	By:	 	 /s/ Douglas B. Trussler

	Name:	 	Douglas B. Trussler
	Title:	 	Managing Member
	
	BISON CAPITAL EQUITY PARTNERS II-B, L.P.
	
	By: BISON CAPITAL PARTNERS II, LLC, its general partner
		
	By:	 	 /s/ Douglas B. Trussler

	Name:	 	Douglas B. Trussler
	Title:	 	Managing Member

 Signature Page to Voting Agreement 

 Exhibit A 
 Questionnaire 
 See attached. 
  

 -11- 

	
	  

	[Print Name]
	  

	[Street Address]
	  

	[City, State and Zip Code]

 THE CENTER FOR WOUND HEALING, INC. 
 QUESTIONNAIRE 
 The information
requested by this Questionnaire is required to complete the required due diligence for The Center for Wound Healing, Inc., a Nevada corporation (the “Company”), All of the proposed directors to be added to the Company’s Board of
Directors are being asked to respond to this Questionnaire. This Questionnaire is intended to obtain information which is not readily available to the Company from its books and records or to confirm certain information. 
 Please answer each question. If any question is not applicable to you, indicate “None” or “Not Applicable.” Unless stated otherwise,
your answers should be given as of the date you complete this Questionnaire. If the space provided for any answer is insufficient, please attach an additional page giving the question number and your answer. If you have some doubt about any
situation, please set forth appropriate facts so that you may be consulted and/or telephone Arthur S. Marcus, Esq. at (212) 752-9700, to discuss the matter. 
 Please complete, sign, date and return one copy of this Questionnaire NO LATER THAN March 19, 2008 to: 
 Arthur S. Marcus, Esq. 
 Gersten Savage LLP 
 600 Lexington Avenue, 9th Floor 
 New York, NY 10022 
 E-mail: amarcus@gskny.com 
  

	1.	Name and Age. 

 If you are, or have been
nominated or chosen to become, a director or an executive officer of the Company, please state your name (as you wish it to appear in the Form S-l) and your date of birth. 
 Answer: 
  

	2.	Positions and Offices. 

 If you are, or have
been nominated or chosen to become, a director or an executive officer of the Company, please state any positions and offices you presently hold or have held with the Company, the terms of all such positions and offices and any periods during which
you have served as such. 
 Answer: 
  

 -1- 

	3.	Arrangements Regarding Your Selection. 

 If
you are, or have been nominated or chosen to become, a director or an executive officer of the Company, please briefly describe any arrangement or understanding between you and any other person or persons (naming such persons) pursuant to which you
were or are to be selected as a director or executive officer. (You need not report any understanding or arrangement with directors or officers of the Company acting solely in their capacities as such.) 
 Answer: 
  

	4,	Family Relationship. 

 If you are, or have been nominated or chosen to become, a director or executive officer of the Company, please state the nature of any family relationship between you and any other person who is, or has been chosen to
become, a director or an executive officer of the Company, or between you and any officer of any “affiliate”1 of the Company. (The term
“family relationship” means any relationship by blood, marriage or adoption, not more remote than first cousin.) 
 Answer: 
  

	5.	Business Experience. 

 (a) If you are, or
have been nominated or chosen to become, a director or executive officer of the Company, please give a brief account of your business experience during the past five years (together with applicable dates), including (i) your principal
occupations and employment during that period, (ii) the name and principal business of any corporation or other organization in which such occupations or employment were carried on and (iii) whether such corporation or organization is a
parent, subsidiary or other affiliate of the Company. 
 Answer: 
 (b) If you are an executive officer of the Company and have been employed by the Company or a subsidiary of the Company for less than five years, briefly explain the nature of your responsibilities in positions held
prior to employment with the Company or its subsidiaries to provide adequate disclosure of your prior business experience. What is required is information relating to the level of your professional competence, which may include, depending on the
circumstances, such specific information as the size of the operation supervised. 
 Answer:
 
  
 1 See Appendix
A for definition of “affiliate.” 
  

 -2- 

 (c) If you are a director or a person nominated or chosen to become a director of the Company, please
disclose any other directorships held by you in any company with a class of securities registered pursuant to Section 12 of the Exchange Act (e.g., companies having securities listed on a national securities exchange) or subject to the
requirements of Section 15(d) of such Act (e.g. , companies which have filed a registration statement that became effective pursuant to the Securities Act of 1933, as amended (the “Securities Act”)) or any company registered as
an investment company under the Investment Company Act of 1940, as amended, naming such company. 
 Answer: 
  

 -3- 

	6.	Involvement in Certain Legal Proceedings. 

 If you are a director, an executive officer or a person nominated to become a director of the Company, please answer the following: 
 (a) During the past ten years, has a petition under the Federal bankruptcy laws, any state insolvency law or foreign bankruptcy proceeding been filed by or against you, or any partnership in which you were a general partner at or within two
years before the time of such filing or appointment, or any corporation or business association of which you were an executive officer at or within two years before the time of such filing, or has a receiver, fiscal agent or similar officer been
appointed for your business or property or any such partnership, corporation or business association? 
 Yes
                                No
             
 If yes, we will contact you for further information. 
 (b) During the past ten years, were you convicted in a federal, state or foreign criminal proceeding (including convictions entered on a plea of nolo
contendere, but excluding traffic violations and other minor offenses) or are you now a named subject of a pending criminal proceeding? 
 Yes
                                No
             
 If yes, we will contact you for further information. 
 (c) During the past ten years, were you the subject of the issuance in a federal, state or foreign civil or administrative proceeding of (i) any
finding, order, judgment or decree (not subsequently reversed, suspended or vacated) relating to an alleged violation of: (A) any securities or commodity laws or regulation; (B) any law or regulation respecting financial institutions,
insurance companies or fiduciary duties owed to a partnership, corporation, business trust or similar business entity, including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil monetary penalty
or temporary or permanent cease-and-desist order, or removal or prohibition order; or (C) any law or regulation prohibiting mail or wire fraud in connection with any business entity; or (ii) an order enjoining or otherwise limiting such
person from engaging in any type of business practice? 
 Yes
                                No
             
 If yes, we will contact you for further information. 
 (d) During the past ten years, were you the subject of the imposition of a sanction by (i) a self-regulatory organization as defined in
Section 3(a)(26) of the Securities Exchange Act of 1934; (ii) a contract market designated pursuant to Section 5 of the Commodity Exchange Act; (iii) a futures association registration under Section 17 of the Commodity
Exchange Act; or (iv) any substantially equivalent foreign authority or organization? 
 Yes
                                No
             
 If yes, we will contact you for further information. 
 For purposes of computing the ten-year period referred to in Questions 6 (a) through (d), the disclosure period applicable to a final conviction,
order, judgment, decree or sanction shall begin with its date of entry. The disclosure period applicable to a preliminary order shall commence when the rights of appeal from such order have lapsed. Any conviction, order, judgment, decree or sanction
that is appealed shall continue to be disclosed until ultimately 

  

 -4- 

 
reversed, suspended, vacated, annulled or otherwise rendered of no effect, at which time disclosure shall no longer be required. With respect to bankruptcy
and insolvency proceedings, the computation date shall be the date of filing for uncontested petitions or the date upon which approval of a contested petition became final. In the case of receiverships and conservatorships, the computation date
shall be the date the receiver or conservator was appointed. 
 In your description, please include any mitigating circumstances associated
with events reported pursuant to Questions 6 (a) through (d). 
  

	7.	Business Relations. 

 If you are a director
or nominee for director of the Company, or were a director or nominee at the end of the Company’s last full fiscal year, please answer the following: 
 (a) If you hold other directorships, do you serve on the compensation committee of another company? 
 Answer: 
 (b) Are you (or were you during the last full fiscal year2) an executive officer of, or do you own (or did you own within the last such year), directly or indirectly, in excess of a 10% equity interest in, any firm,
corporation or other business or professional entity: 
 (i) which made during the Company’s last full fiscal year (or proposes to make
during the current fiscal year) payments to the Company or any of its subsidiaries for property’ or services in excess of (x) $25,000 or (y) five percent of the other entity’s consolidated gross revenues for such last full fiscal
year (excluding payments where rates are determined by competitive bidding or where the transaction involves the services of a public utility at rates fixed by law); 
 (ii) to which the Company or any of its subsidiaries made during such entity’s last full fiscal year (or proposes to make during such entity’s current fiscal year) payments in excess of (x) $25,000 or
(y) five percent of the other entity’s consolidated gross revenues for such last full fiscal year (excluding payments of the type referred to in the previous paragraph); 
 (iii) to which the Company or any of its subsidiaries was indebted (excluding indebtedness in respect of publicly traded debt securities) at the end of
the Company’s last full fiscal year in an aggregate amount in excess of $25,000? 
 If your answer is affirmative, please describe the
circumstances, including your position or interest in the entity involved in the transaction, the property or services for which payment %was made, the amount of such payments during the periods indicated by the question, and the amount of business
proposed to be done between the entity involved and the Company or any of its affiliates in the current fiscal year. 
  

	2	The Company’s 2007 fiscal year began on January 1. 2007 and ended on December 31, 2007. 

  

 -5- 

 Answer: 
 (c)
Are you (or were you during the Company’s last full fiscal year) a member of, or of counsel to, a law firm which the Company has retained in the last full fiscal year or proposes to retain in the current fiscal year? If your answer is
affirmative, please describe the circumstances and indicate whether the dollar amount of the fees paid by the Company to such firm exceeds five percent of the firm’s consolidated gross revenues for its last full fiscal year. 
 Answer: 
 (d) Are you now (or were you at any time during the
Company’s last full fiscal year) a partner or executive officer of an investment banking firm which has performed services for the Company (other than as a participating underwriter in a syndicate) in the last full fiscal year or which the
Company proposes to have perform services for it in the current fiscal year? If your answer is affirmative, please describe the circumstances and indicate whether the dollar amount of the fees paid by the Company to such firm exceeds five percent of
the firm’s consolidated gross revenues for its last full fiscal year. 
 Answer: 
 (e) Do you know of any arrangements for indemnification of any or all directors or officers against liabilities incurred in those capacities, other than
pursuant to any statutory, charter, or bylaw provision? If yes, please fully describe the arrangement. 
 Answer: 
 (f) Is there any other relationship substantially similar in nature and scope to those relationships listed in Question 7(a), (b), (c), (d) or
(e) above? If any such relationship exists, please describe it. 
 Answer: 
  

	8.	Indebtedness to the Company. 

 If you are a
director, an executive officer or a person nominated to be a director of the Company, and if (a) you, (b) any member of your “immediate family,”3 (c) any trust or other estate in which you have a substantial 
  

	3	See Appendix A for definition of “immediate family.” 

  

 -6- 

 beneficial interest or as to which you serve as a trustee or other fiduciary or (d) any corporation or other
organization of which you are an executive officer or partner or are, directly or indirectly, the beneficial owner of 10% or more of any class of equity securities, was indebted to the Company or any of its subsidiaries at any time since the
beginning of the Company’s last full fiscal year, state (i) the largest aggregate amount of indebtedness outstanding at any time during the period, (ii) the nature of the indebtedness and of the transaction(s) in which it was incurred
(iii) the amount of indebtedness outstanding as of the latest practicable date and (iv) the rate of interest paid or charged. If indebtedness of any person other than you is described, name that person and give the nature of the
relationship. 
 NOTE: You need not answer this question if your aggregate indebtedness to the Company or its subsidiaries, or the aggregate indebtedness of
any other person specified in the previous paragraph to the Company or its subsidiaries, at any time during the last fiscal year did not exceed $60,000. In determining the amount of indebtedness, exclude all amounts due for purchases subject to
usual trade terms, for ordinary travel and expense advances and for other transactions in the ordinary course of business. It is the view of the Commission that an indebtedness may arise to the Company if you realize any profit which would result
from a matching of any purchase with any sale of the Company’s common stock effected within a period of six months within the meaning of Section 16(b) of the Exchange Act. 
 Answer: 
  

	9.	Certain Transactions. 

 If you are a
director, an executive officer or a person nominated to be a director of the Company, and you or any member of your “immediate family”4
had any material interest, direct or indirect, in a transaction with the Company or any of its subsidiaries during the Company’s last full fiscal year, or if any of you have any such interest in any proposed transaction with the Company or any
of its subsidiaries, please briefly describe the transaction(s), the nature of the interest in the transaction, and, where practicable, give the amount of such interest. If it is not practicable to give the amount of the interest, give the amount
involved in the transaction. If the transaction involves a person other than you, name the person and state the nature of your relationship to the person. 
 Information should be furnished with respect to transactions that involve remuneration from the Company or its subsidiaries, directly or indirectly, to any of the persons listed above for services in any capacity
unless the interest of such person arises solely from the ownership individually and in the aggregate of less than 10% of any class of equity securities of another corporation furnishing the services to the Company or its subsidiaries. 

If such transaction involved or is to involve the purchase or sale of assets by or to the Company or any of its subsidiaries otherwise than in the
ordinary course of business, please state the cost of the assets to the purchaser and the cost thereof to the seller, if acquired by the seller within two years prior to the transaction. Indicate the principle followed in determining the
Company’s purchase or sale price and the name of the person making such determination. Please make a separate statement with respect to each transaction. 
 NOTE: A. You need not give any information as to any transaction or interest in a transaction if: 
 (i) the rates or charges
involved in the transaction are determined by competitive bids, or the transaction involves the rendering of services as a common or contract carrier, or public utility, at rates or charges fixed in conformity with law or governmental authority;

  

	4	See Appendix A for definition of “immediate family.” 

  

 -7- 

 (ii) the transaction involves services as a bank depository of funds, transfer agent, registrar, trustee
under a trust indenture, or similar services; 
 (iii) the amount involved in the transaction or in a series of similar transactions
(including all periodic installments in the case of any or other agreement providing for periodic payments or installments) does not exceed $60,000; or 
 (iv) the interest of the persons referred to in the first sentence of this question arises solely from the ownership of securities of the Company and such person receives no extra or special benefit not shared on a
pro rata basis. 
 B. A person who has a position or relationship with a firm, corporation or other entity which engages in a transaction
with the Company or its subsidiaries may have an indirect interest in such transaction by reason of such position or relationship. However, a person will not be deemed to have an indirect interest in a transaction if: 
 (i) the interest in the transaction arises only (x) from a position as a director of another corporation or organization (other than a partnership)
which is a party to the transaction, (y) from the direct or indirect ownership by you and all other persons referred to in the first sentence of this question of less than a 10% equity interest in the other party to the transaction or
(z) from both such position and ownership; 
 (ii) the interest in such transaction arises only from a position as a limited partner in
a partnership in which you and all other persons referred to in the first sentence of this question have or had an interest of less than 10%; or 
 (iii) the interest arises solely from the holding of an equity interest (including a limited partnership interest, but excluding an interest in a general partnership) or a creditor interest in the other party to the transaction and the
transaction is not material to such other party. 
 Answer: 
  

	10.	Legal Proceedings Involving the Company. 

 Are you or any of your “associates”5 a party adverse to the Company, or do you or any of your associates have a material interest
adverse to the Company, in any legal proceeding to which the Company or a subsidiary of the Company is a party or of which any of their property is the subject? If your answer is affirmative, please give the name of the court or agency where the
proceeding is pending, the date it was instituted, the principal parties thereto, a description of the factual basis alleged to underlie the proceeding and the relief sought. Please give similar information as to any such proceeding known to be
contemplated by any governmental authority. 
 Answer: 
  

	5	See Appendix A for definition of “associate.” 

  

 -8- 

	11.	Beneficial Ownership of the Company’s Equity Securities. 

 (a) If you are a director, an executive officer or a person who has been nominated to become a director of the Company, or a five percent (5%) or more shareholder in the Company, please furnish the information
called for below concerning your beneficial ownership of each class of equity securities of the Company on December 31, 2007. 
 NOTE: For purposes of
this question, you are deemed to be the beneficial owner of a security when through any contract, arrangement, understanding, relationship, or otherwise, you have or share (i) the power to vote or to direct the voting of the security and/or
(ii) the power to dispose, or to direct the disposition, of the security. You are also regarded as the beneficial owner of a security which you have the right to beneficially acquire (which includes the right to acquire the voting power and/or
investment power of such security) at any time within 60 days through the exercise of any option, warrant or right, or through the conversion of a security, or pursuant to a power to revoke a trust, discretionary account, or similar arrangement, or
pursuant to an automatic termination of a trust, discretionary account or similar arrangement. You are also regarded as the beneficial owner of a security if you directly or indirectly created a trust, proxy, power of attorney, pooling arrangement
or any other contract, arrangement, or device, with the purpose or effect of divesting yourself of beneficial ownership of the security or preventing the vesting of such beneficial ownership as part of a plan or scheme to evade reporting
requirements. 
  

							
	 Title of
Class of
Equity
Security
	 	Number of
Shares Presently
Beneficially
Owned	 	Number of
Shares Which
You Have
the Right
to
Beneficially
Acquire Within
60 Days	 	Nature of
the Right

 (b) If you wish to disclaim beneficial ownership of some or all of the securities listed in
Question 1l(a) above, please furnish the following information with respect to the person or persons who should be shown as the beneficial owner(s) of the securities in Question 1l(a) and state the rationale for such disclaimer. 
  

					
	 Name of
 Beneficial
 Owner
	 	 Relationship
 of Such
 Person to
You
	 	 Number of Shares
 Beneficially Owned
 by Such Person

 (c) If you share the power to vote or direct the voting of or to dispose or direct the disposition
of any of the securities referred to in response to Question 11 (a), please indicate the securities as to which each power is and is not shared. 
  

							
	 Number of
Shares as
to Which
Voting
Power Is
Not Shared
	 	Number of
Shares as
to Which
Voting
Power Is
Shared	 	Number of
Shares as
to Which
Investment
Power is
Not Shared	 	Number of
Shares as
to Which
Investment
Power Is
Shared

 (d) If you are, or have been nominated or chosen to become, a director or executive officer of the
Company, 
  

 -9- 

 please state whether, to the best of your knowledge, any person,
corporation, firm, entity or “group”6 owns beneficially more than five percent of any class of the Company’s voting securities? If
your answer is “yes,” please identify such person, corporation, firm, entity or “group” and, if practicable, give the total number of shares beneficially owned the of class so owned. 
 Yes
                                No
             
 Answer: 
  

	12.	Changes in Control of the Company. 

 (a) If you are, or have been nominated or chosen to become, a director or executive officer of the
Company, are you aware of any change in “control”7 of the Company that has occurred since the beginning of the Company’s last full
fiscal year? 
 Yes
                                No
             
 If yes, we will contact you for further information. 
 (b) If you are, or have been nominated or chosen to become, a director or executive officer of the Company, are you aware of any arrangements, including
any pledge of the Company’s securities, the operation of which may at a subsequent date result in a change of control of the Company? 
 Yes
                                No
             
 If yes, we will contact you for further information. 
  

	13.	Unregistered Sales of Equity Securities. 

 Please furnish the following information as to which you have knowledge, as to all equity securities of the Company or any of its affiliates sold by the Company or any of its affiliates within the past three (3) years which were not
registered under the Securities Act. Include sales of reacquired equity securities as well as new issues, securities issued in exchange for property, services or other securities, and new equity securities resulting from the modification of
outstanding securities: 
  

	 	(a)	Date of sale, title of equity securities, and amount sold. 

  

	 	(b)	Names of the persons or identities of the class of persons to whom the equity securities were sold. 

  

	 	(c)	As to any equity securities sold for cash, the aggregate offering price and the aggregate underwriting discounts or commissions. 

  

	 6
	 See Appendix A for definition of “group.” 

	 7
	 See Appendix A for definition of “control.” 

  

 -10- 

	 	(d)	As to any equity securities sold otherwise than for cash, the nature of the transaction and the aggregate amount of consideration received. 

  

	 	(e)	The name of the principal underwriters, if any. 

 * * * * *

 The undersigned has furnished the information called for in this Questionnaire expressly for use in connection with the preparation and
filing of the Company’s Registration Statement on Form S-l, THE UNDERSIGNED REPRESENTS AND WARRANTS TO ANY PERSONS WHO MAY BE LIABLE IN RESPECT OF THE PERIOD REPORTS FILED PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 AND GERSTEN SAVAGE, THAT
TO THE BEST OF THE KNOWLEDGE, INFORMATION AND BELIEF OF THE UNDERSIGNED, THE ANSWERS GIVEN IN THIS QUESTIONNAIRE ARE TRUE AND CORRECT AND DO NOT OMIT ANY FACTS REQUIRED FOR A PROPER ANSWER TO ANY ITEM STATED HEREIN. The undersigned shall promptly
advise the Company if the undersigned becomes aware of any event which occurs while you are a director of the Company which might require any change in the answers to these questions. 
  

							
	 Date: March     , 2008.
	 		 	  
	 	
		 		 	 [Signature]
	 	

  

 -11- 

 APPENDIX A 
 “Affiliate.” An “affiliate” of a person means a person or other entity that directly or indirectly, through one or more intermediaries, “controls” (as in the case of a parent company), or
is “controlled by” in the case of a subsidiary), or is under common control with such person. 
 “Associate.” An
“associate” of a person means (i) any corporation or organization (other than the Company, or a majority-owned subsidiary of the Company), of which such person is an officer or partner or is, directly or indirectly, the beneficial
owner of 10% or more of any class of equity securities, (ii) any trust or estate in which such person has a substantial beneficial interest, or as to which such person serves as a trustee or other fiduciary, (iii) such person’s
spouse, or any relative of such person or such person’s spouse, who has the same home as such person or who is a director or officer of the Company or any of its subsidiaries. 
 “Control.” The terms “control,” “controlling,” “controlled by” and “under common control with” mean the
possession, direct or indirect, of the power to direct or cause the direction of the management and policies of the Company, whether by ownership of voting securities, by contract or otherwise. 
 “Executive Officer.” The term “executive officer” means the Chairman of the Board, Vice-Chairman of the Board, President, any
Vice-President that is the head of a principal business division, group, unit or function (e.g., sales, administration or finance), any other officer performing a “policy-making” function or any person performing closely related
“policy-making” functions for the Company. In the case of a subsidiary, if an executive officer of a subsidiary performs “policy-making” functions for the Company, that person may be deemed to be an executive officer of the
Company. 
 “Group.” A “ group” includes any two or more persons who act as a partnership, limited partnership,
syndicate, or other group, or otherwise acting in concert for the purpose of acquiring, holding, voting or disposing of equity securities of the Company. 
 “Immediate family.” Persons considered members of the immediate family are spouses, parents, children, siblings, mothers- and fathers-in-law, sons- and daughters-in-law and brothers- and sisters-in-law.

 “Significant Employee.” The term “significant employee” refers to employees of the Company (e.g., managers)
that are not “executive officers” but that make significant contributions to the business of the Company. 

 Exhibit B 
 Proxy 
 The undersigned holder of stock (“Stockholder”) of THE
CENTER FOR WOUND HEALING, INC., a Nevada corporation (the “Company”), hereby irrevocably (to the fullest extent permitted by law) appoints Douglas B. Trussler, as the sole and exclusive attorney of the undersigned, with
full power of substitution and resubstitution, to vote and exercise all voting and related rights (to the full extent that the undersigned is legally entitled to do so) with respect to the matters referred to in Sections 1 and 2 of that
certain Voting Agreement, dated as of March 31, 2008 (the “Voting Agreement”), by and among BISON CAPITAL EQUITY PARTNERS II-A, L.P., a Delaware limited partnership, and BISON CAPITAL EQUITY PARTNERS II-B,
L.P., a Delaware limited partnership (collectively, “Purchaser”), the Company, and certain stockholders of the Company, for all equity interests in the Company having voting rights now owned or hereafter acquired by the
undersigned (the “Interests”). 
 1. This Proxy is granted pursuant to the Voting Agreement and is granted in
consideration of Bison entering into that certain Securities Purchase Agreement, dated as of March 31, 2008, by and between the Company and Purchaser (the “Purchase Agreement”). 
 2. Upon the undersigned’s execution of this Proxy, any and all prior powers of attorney and proxies given by the undersigned with respect to any
Interests, to the extent related to the matters set forth in Section 3 of this Proxy, are hereby revoked, and the undersigned agrees not to grant any subsequent powers of attorney or proxies with respect to the Interests to the extent related
thereto until after the termination of the Voting Agreement (the “Expiration Date”). 
 3. The attorney and appointee
named above, and each of them, are hereby authorized and empowered by the undersigned, at any time prior to the Expiration Date, to act as the undersigned’s attorney and nominee to vote the Interests, and to exercise all voting, consent and
similar rights of the undersigned with respect to the Interests (including, without limitation, the power to execute and deliver written consents) at every annual, special, postponed or adjourned meeting of the shareholders of the Company and in
every written consent in lieu of such meeting, and the right to sign its name (solely in its capacity as a stockholder) to any consent, certificate or other document relating to the Company that the laws of the State of Nevada may permit or require:

 a. in favor of the election of two persons designated from time to time by Purchaser (the “Bison Representatives”)
to the board of directors of the Company; 
 b. upon the occurrence of an Event of Default (as defined in the Purchase Agreement) and at the
request of Purchaser, in favor of the removal of such directors of the Company as may be necessary to allow for the immediate election of that certain number of directors which together with the two Bison Representatives would constitute a majority
of the members of the board of directors of the Company; 
 c. upon the occurrence of an Event of Default and at the request of Purchaser, in
favor of the election of such persons as may be necessary to constitute, together with the two Bison Representatives, a majority of the members board of directors of the Company, as such persons may be designated by Purchaser at the time of such
Event of Default (the “Bison Default Representatives”); 
  

 -12- 

 d. upon the request of Purchaser, in favor of the removal of Bison Representatives or Bison Default
Representatives and the election of such persons as may be designated by Purchaser to succeed such representatives; and 
 e. against any
proposal or action to which Purchase has not consented in writing that would cause the number of authorized number directors of the Company to exceed seven (7). 
 4. This Proxy is irrevocable (to the fullest extent permitted by law) and is coupled with an interest. This Proxy shall terminate, and be of no further force and effect, automatically upon the Expiration Date

 5. For sake of clarification, nothing in this Proxy shall confer upon the attorney named above the right to exercise control or direction
over the voting rights attached to the Interests in any circumstance other than the limited circumstances expressly referred to herein. The undersigned Stockholder may vote the Interests on all other matters. 
 6. Any obligation of the undersigned Stockholder hereunder shall be binding upon the successors and assigns of the undersigned Stockholder. 

7. If any term or provision of this Proxy or any part of any such term or provision is held under any circumstances to be invalid or unenforceable in
any jurisdiction, then (a) such term or provision or part thereof will, with respect to such circumstances and in such jurisdiction, be deemed amended to conform to applicable laws so as to be valid and enforceable to the fullest permitted
extent, (b) the invalidity or unenforceability of such term or provision or part thereof under such circumstances and in such jurisdiction shall not affect the validity or enforceability of such term or provision or part thereof under any other
circumstances or in any other jurisdiction, and (c) the invalidity or unenforceability of such term or provision or part thereof shall not affect the validity or enforceability of the remainder of such term or provision or the validity or
enforceability of any other term or provision of this Proxy. Each term and provision of this Proxy is separable from every other term or provision of this Proxy, and each part of each term or provision of this Proxy is separable from every other
part of such term or provision. 
 8. The Interests beneficially owned by the undersigned Stockholder as of the date of this Proxy are listed
on the final page of this Proxy. 
 [Signature appears on following page] 
  

 -13- 

 IN WITNESS WHEREOF, the undersigned Stockholder has caused this Proxy to be duly executed on the day and
year written next below. 
 Dated: 3/31/08 
  

							
	Signature of Shareholder:	 		 	 /s/ JOHN CAPOTORTO

			
	Print Name of Shareholder:	 		 	 JOHN CAPOTORTO

			
	Shares Beneficially Owned:	 		 	

  

									
		 	             shares of capital stock of the Company
		
		 	             shares of Capital stock of Company issuable upon the exercise of outstanding options, warrants, or
other rights or upon conversion of outstanding notes or other convertible securities

 IN WITNESS WHEREOF, the undersigned Stockholder has caused this Proxy to be duly executed on the day and
year written next below. 
 Dated: March 29, 2008 
  

					
	 Signature of Shareholder:
	 		 	 /s/ Paul Basmajian

  

					
	 Print Name of Shareholder:
	 		 	Paul Basmajian

  

					
	 Shares Beneficially Owned:
	 	

  

					
		 	             shares of capital stock of the Company
		
		 	50,000 shares of Capital stock of Company issuable upon the exercise of outstanding options, warrants, or other rights or upon conversion of outstanding notes or other
convertible securities

  

 -15- 

 IN WITNESS WHEREOF, the undersigned Stockholder has caused this Proxy to be duly executed on the day and
year written next below. 
 Dated: 3/31/08 
  

			
	 Signature of Shareholder:
	 	 /s/ David H. Meyrowitz

		
	 Print Name of Shareholder:
	 	 David H. Meyrowitz

		
	 Shares Beneficially Owned:
	 	

  

					
		 	70,000 shares of capital stock of the Company
		
		 	             shares of Capital stock of Company issuable upon the exercise of outstanding options, warrants, or
other rights or upon conversion of outstanding notes or other convertible securities

  

 -15- 

 IN WITNESS WHEREOF, the undersigned Stockholder has caused this Proxy to be duly executed on the day and
year written next below. 
 Dated: March 30, 2008 
  

			
	 Signature of Shareholder:
	 	 /s/ DAVID J. WALZ

		
	 Print Name of Shareholder:
	 	 DAVID J. WALZ

		
	 Shares Beneficially Owned:
	 	

  

			
		 	              shares of capital stock of the
Company

		
		 	210,000 shares of Capital stock of Company issuable upon the exercise of outstanding options, warrants, or other rights or upon conversion of outstanding notes or other convertible
securities

  

 -15- 

 N WITNESS WHEREOF, the undersigned Stockholder has caused this Proxy to be duly executed on the day and
year written next below. 
 Dated: 3/31/08 

			
	 Signature of Shareholder:
	 	 /s/ ANDREW G. BARNETT

		
	 Print Name of Shareholder:
	 	ANDREW G. BARNETT
		
	 Shares Beneficially Owned:
	 	

  

			
		 	             shares of capital stock of the Company
		
		 	1,750,000* shares of Capital stock of Company issua ble upon the exercise of outstanding options, warrants, or other rights or upon conversion of outstanding notes or other convertible
securities
	
	* under terms of new employment agreement

  

 -15- 

 IN WITNESS WHEREOF, the undersigned Stockholder has caused this Proxy to be duly executed on the day and
year written next below. 
 Dated: 15th March 2008 
  

			
	Signature of Shareholder:	 	 /s/ CINDY GLASBY

		
	Print Name of Shareholder:	 	CINDY GLASBY for THE ELISE TRUST
	
	Shares Beneficially Owned:

  

					
		 	6,375,848 shares of capital stock of the Company
		
		 	    0     shares of Capital stock of Company issuable upon the exercise of outstanding options, warrants, or other rights or upon
conversion of outstanding notes or other convertible securities

  

 -14- 

 IN WITNESS WHEREOF, the undersigned Stockholder has caused this Proxy to be duly executed on the day and
year written next below. 
 Date: 3/31/08 
  

			
	Signature of Shareholder:	 	 /s/ Phillip Forman

		
	Print Name of Shareholder:	 	Phillip Forman
		
	Shares Beneficially Owned:	 	

			
	
	              shares of capital stock of the Company

	
	              shares of Capital stock of Company issuable upon the exercise of
outstanding options, warrants, or other rights or upon conversion of outstanding notes or other convertible securities

  

 -15- 

 Exhibit C 
 Joinder Agreement 
  

			
	 The undersigned
                                       
 , by executing this Joinder Agreement dated as of
                                       
 , 200    , does hereby acknowledge the terms of, and agree to be bound as a “Stockholder” under, that certain Voting Agreement dated as of March 31, 2008 by and among THE CENTER FOR WOUND HEALING,
INC., a Nevada corporation, BISON CAPITAL EQUITY PARTNERS II-A, L.P., a Delaware limited partnership, and BISON CAPITAL EQUITY PARTNERS II-B, L.P., a Delaware limited partnership, and the Stockholders listed on the signature pages thereto (the term
“Stockholder” having the meaning ascribed to it in the Voting Agreement).

	
	 Any notice required or permitted under the Voting Agreement shall be sent to the undersigned at the following address, or at such address as the
undersigned may designate in accordance with the terms of the Voting Agreement:

		
	 Address:
	 	  

			
	  

	  

	  

 [Name of New Stockholder] 
  

 -15- 

 Exhibit D 
 Interests 
 John Capotorto: 4,575,848 shares of common stock 
 Phillip Forman: 4,575,848 shares of common stock 
 David J. Walz: Options to
purchase up to 210,000 shares of common stock 
 Andrew Barnett: Option to purchase up to 1,000,000 shares of common stock 
 The Elise Trust: 4,575,848 shares of common stock 
 Paul Basmasjian: 16,667
shares of common stock 
 David H. Meyrowitz: 20,000 shares of common stock 
  

 -16- 

 Exhibit G 
 Addresses 
 Company: 
 The Center For Wound Healing, Inc. 
 155 White Plains Road Suite 200 
 Tarrytown, New York 10591 
 Facsimile: (914) 372-3151 
 Email: Andrew.Barnett@CenterWH.com 
 Attention: Mr. Andrew Barnett, CEO 
 with a copy to, which shall not constitute notice: 
 Gersten Savage LLP

 600 Lexington Avenue 
 New York, New York 1002 
 Facsimile: (212) 980-5192 
 Email: AMarcus@gskny.com 
 Attention: Arthur S. Marcus, Partner 
 and: 
 King & Spalding LLP 
 1185 Avenue of the Americas 
 New York, New York 10036-4003 
 Facsimile: (212) 556-2222 
 Email: BSeidel@KSLAW.com 
 Attention: Barry Seidel, Esq. 
 Purchaser: 
 Bison Capital Equity Partners II-A, L.P. 
 Bison Capital Equity Partners II-B, L.P. 
 10877 Wilshire Blvd., Suite 1520

 Los Angeles, California 90024 
 Facsimile: (310) 260-6576

 Email: dtrussler@bisoncapital.com 
 Attention:
Mr. Douglas B. Trussler 
 with a copy to: 
 Sheppard
Mullin Richter & Hampton LLP 
 333 South Hope Street, 48th Floor 
 Los Angeles, California 90071 
 Facsimile: (213) 620-1398 
 Email: dsands@smrh.com 
 Attention: David Sands 
  

 -17- 

 Stockholders: 
 JOHN
CAPOTORTO: 
 301 E 79TH ST #18H 
 NEW YORK NY 10021

 PHILLIP FORMAN: 
 ONE LOCKWOOD RUN 
 COLTS NECK NJ 07722 
 DAVID J. WALZ: 
 18 HOPE VIEW COURT 
 MIDDLE HOPE, NEW YORK 12550 
 ANDREW G. BARNETT: 
 518 CHEESE SPRING ROAD 
 NEW CANAAN, CT 06840 
 THE ELISE TRUST: 
 C/O ELISE GREENBERG 
 P O BOX 562 
 GOLDENSBRIDGE NY 10526 
 PAUL BASMASJIAN: 
 8 PATRIOTS FARM CT 
 ARMONK NY 10504 
 DAVID H. MEYROWITZ: 
 C/O SIMON MEYROWITZ & MEYROWITZ 
 470 PARK AVE - 12TH FL 
 NEW YORK NY 10016 
  

 -18-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]